| Year |
Citation |
Score |
| 2024 |
Fava M, Stahl SM, Pani L, De Martin S, Cutler AJ, Maletic V, Gorodetzky CW, Vocci FJ, Sapienza FL, Kosten TR, Kröger C, Champasa P, O'Gorman C, Guidetti C, Alimonti A, et al. Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial. The Journal of Clinical Psychiatry. 85. PMID 38917366 DOI: 10.4088/JCP.24m15265 |
0.461 |
|
| 2024 |
Guidetti C, Feeney A, Hock RS, Iovieno N, Hernández Ortiz JM, Fava M, Papakostas GI. Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis. International Clinical Psychopharmacology. PMID 38869978 DOI: 10.1097/YIC.0000000000000554 |
0.364 |
|
| 2024 |
Crawford CM, Fallucco E, Fava M, Ingelfinger J, Scott-Vernaglia S. Depression - Screening and Treating Depression in Adolescents. The New England Journal of Medicine. 390: e56. PMID 38865659 DOI: 10.1056/NEJMp2400711 |
0.509 |
|
| 2024 |
Lee MK, Kim SW, Kim H, Park MJ, Fava M, Mischoulon D, Jeon HJ. Association between cerebral artery stenosis and depressive symptoms in elderly patients. Journal of Affective Disorders. PMID 38844169 DOI: 10.1016/j.jad.2024.06.016 |
0.406 |
|
| 2024 |
Cristancho M, Fava M, Ingelfinger J, Nikayin S, Sanacora G. Depression - Advanced Treatments for Treatment-Resistant Depression. The New England Journal of Medicine. 390: e44. PMID 38810184 DOI: 10.1056/NEJMp2310181 |
0.563 |
|
| 2024 |
Dillon DG, Belleau EL, Origlio J, McKee M, Jahan A, Meyer A, Souther MK, Brunner D, Kuhn M, Ang YS, Cusin C, Fava M, Pizzagalli DA. Using Drift Diffusion and RL Models to Disentangle Effects of Depression On Decision-Making vs. Learning in the Probabilistic Reward Task. Computational Psychiatry (Cambridge, Mass.). 8: 46-69. PMID 38774430 DOI: 10.5334/cpsy.108 |
0.321 |
|
| 2024 |
Guidetti C, De Martin S, Serra G, Apicella M, Pani L, Pappagallo M, Mattarei A, Folli F, Manfredi P, Fava M. Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017). The Journal of Clinical Psychiatry. 85. PMID 38767937 DOI: 10.4088/JCP.22m14735 |
0.574 |
|
| 2024 |
Anderson E, Crawford CM, Fava M, Ingelfinger J, Sanacora G, Scott-Vernaglia S, Teel J. Depression - Treatment Options and Managing Depression in Primary Care. The New England Journal of Medicine. 390: e44. PMID 38749042 DOI: 10.1056/NEJMp2310180 |
0.524 |
|
| 2024 |
Anderson E, Crawford CM, Fava M, Ingelfinger J, Nikayin S, Sanacora G, Scott-Vernaglia S, Teel J. Depression - Understanding, Identifying, and Diagnosing. The New England Journal of Medicine. 390: e41. PMID 38692291 DOI: 10.1056/NEJMp2310179 |
0.567 |
|
| 2024 |
Schmidt ME, Kezic I, Popova V, Melkote R, Van Der Ark P, Pemberton DJ, Mareels G, Canuso CM, Fava M, Drevets WC. Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 38649428 DOI: 10.1038/s41386-024-01862-x |
0.45 |
|
| 2024 |
Papakostas GI, Trivedi MH, Shelton RC, Iosifescu DV, Thase ME, Jha MK, Mathew SJ, DeBattista C, Dokucu ME, Brawman-Mintzer O, Currier GW, McCall WV, Modirrousta M, Macaluso M, Bystritsky A, ... ... Fava M, et al. Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial. Molecular Psychiatry. PMID 38454079 DOI: 10.1038/s41380-024-02468-x |
0.492 |
|
| 2023 |
Murck H, Fava M, Cusin C, Fatt CC, Trivedi M. Brain ventricle and choroid plexus morphology as predictor of treatment response in major depression: Findings from the EMBARC study. Brain, Behavior, & Immunity - Health. 35: 100717. PMID 38186634 DOI: 10.1016/j.bbih.2023.100717 |
0.439 |
|
| 2023 |
Nyer MB, Hopkins LB, Nagaswami M, Norton R, Streeter CC, Hoeppner BB, Sorensen CEC, Uebelacker L, Koontz J, Foster S, Dording C, Giollabhui NM, Yeung A, Fisher LB, Cusin C, ... ... Fava M, et al. A Randomized Controlled Trial of Community-Delivered Heated Hatha Yoga for Moderate-to-Severe Depression. The Journal of Clinical Psychiatry. 84. PMID 37883245 DOI: 10.4088/JCP.22m14621 |
0.301 |
|
| 2023 |
Fava M. The challenges of defining and managing treatment-resistant depression in research and practice. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 350-351. PMID 37713579 DOI: 10.1002/wps.21128 |
0.402 |
|
| 2023 |
Giles MA, Cooper CM, Jha MK, Chin Fatt CR, Pizzagalli DA, Mayes TL, Webb CA, Greer TL, Etkin A, Trombello JM, Chase HW, Phillips ML, McInnis MG, Carmody T, Adams P, ... ... Fava M, et al. Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial. Behavioral Sciences (Basel, Switzerland). 13. PMID 37622759 DOI: 10.3390/bs13080619 |
0.433 |
|
| 2023 |
Riesenberg R, Yeung PP, Rekeda L, Sachs GS, Kerolous M, Fava M. Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Clinical Psychiatry. 84. PMID 37585254 DOI: 10.4088/JCP.22m14643 |
0.359 |
|
| 2023 |
Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X. A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression. International Journal of Molecular Sciences. 24. PMID 37569888 DOI: 10.3390/ijms241512513 |
0.365 |
|
| 2023 |
Gomeni R, Bressolle-Gomeni F, Fava M. A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence. Psychiatry Research. 327: 115367. PMID 37544088 DOI: 10.1016/j.psychres.2023.115367 |
0.339 |
|
| 2023 |
Mac Giollabhui N, Mischoulon D, Dunlop BW, Kinkead B, Schettler PJ, Liu RT, Okereke OI, Lamon-Fava S, Fava M, Rapaport MH. Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial. Brain, Behavior, & Immunity - Health. 32: 100666. PMID 37503359 DOI: 10.1016/j.bbih.2023.100666 |
0.312 |
|
| 2023 |
Gomeni R, Bressolle-Gomeni F, Fava M. Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo. Translational Psychiatry. 13: 141. PMID 37120641 DOI: 10.1038/s41398-023-02443-0 |
0.388 |
|
| 2023 |
Kim H, Jung JH, Han K, Lee DY, Fava M, Mischoulon D, Jeon HJ. Ages at menarche and menopause, hormone therapy, and the risk of depression. General Hospital Psychiatry. 83: 35-42. PMID 37043925 DOI: 10.1016/j.genhosppsych.2023.04.001 |
0.439 |
|
| 2023 |
Kim YR, Lauze MS, Slattery M, Perlis RH, Holsen LM, Breithaupt L, Stern CM, Fava M, Thomas JJ, Lawson EA, Misra M, Eddy KT. Association Between Ghrelin and Body Weight Trajectory in Individuals With Anorexia Nervosa. Jama Network Open. 6: e234625. PMID 36961462 DOI: 10.1001/jamanetworkopen.2023.4625 |
0.561 |
|
| 2023 |
Murck H, Fava M, Cusin C, Chin-Fatt C, Trivedi M. Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study. Research Square. PMID 36909585 DOI: 10.21203/rs.3.rs-2618151/v1 |
0.3 |
|
| 2023 |
Fava M, Stahl SM, De Martin S, Mattarei A, Bettini E, Comai S, Alimonti A, Bifari F, Pani L, Folli F, Guidetti C, Furlan A, Sgrignani J, Locatelli P, Cavalli A, et al. Esmethadone-HCl (REL-1017): a promising rapid antidepressant. European Archives of Psychiatry and Clinical Neuroscience. PMID 36890259 DOI: 10.1007/s00406-023-01571-4 |
0.309 |
|
| 2023 |
Guidetti C, Serra G, Pani L, Pappagallo M, Maglio G, Martin S, Mattarei A, Folli F, Manfredi PL, Fava M. Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder. The Primary Care Companion For Cns Disorders. 25. PMID 36821775 DOI: 10.4088/PCC.22m03267 |
0.371 |
|
| 2023 |
Sachs GS, Yeung PP, Rekeda L, Khan A, Adams JL, Fava M. Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. The American Journal of Psychiatry. appiajp20220504. PMID 36789515 DOI: 10.1176/appi.ajp.20220504 |
0.473 |
|
| 2023 |
Correll CU, Solmi M, Cortese S, Fava M, Højlund M, Kraemer HC, McIntyre RS, Pine DS, Schneider LS, Kane JM. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 48-74. PMID 36640403 DOI: 10.1002/wps.21056 |
0.318 |
|
| 2023 |
Lamon-Fava S, Liu M, Dunlop BW, Kinkead B, Schettler PJ, Felger JC, Ziegler TR, Fava M, Mischoulon D, Rapaport MH. Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36635595 DOI: 10.1038/s41386-022-01527-7 |
0.398 |
|
| 2022 |
Hock RS, Feeney A, Iovieno N, Murrough JW, Mathew SJ, Iosifescu DV, Fava M, Jha MK, Papakostas GI. Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis. The Journal of Clinical Psychiatry. 84. PMID 36516320 DOI: 10.4088/JCP.21r14086 |
0.502 |
|
| 2022 |
Dirks B, Fava M, Atkinson SD, Joyce M, Thase ME, Howell B, Lin T, Stankovic S. Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies. Psychopharmacology Bulletin. 52: 8-30. PMID 36339271 |
0.512 |
|
| 2022 |
Stahl SM, De Martin S, Mattarei A, Bettini E, Pani L, Guidetti C, Folli F, de Somer M, Traversa S, Inturrisi CE, Pappagallo M, Gentilucci M, Alimonti A, Fava M, Manfredi PL. Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling. International Journal of Molecular Sciences. 23. PMID 36293063 DOI: 10.3390/ijms232012196 |
0.417 |
|
| 2022 |
Kim H, Kim Y, Shin MH, Park YJ, Park HE, Fava M, Mischoulon D, Park MJ, Kim EJ, Jeon HJ. Early psychiatric referral after attempted suicide helps prevent suicide reattempts: A longitudinal national cohort study in South Korea. Frontiers in Psychiatry. 13: 607892. PMID 36147991 DOI: 10.3389/fpsyt.2022.607892 |
0.305 |
|
| 2022 |
Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED, Zarate CA, Deakin W, Abdallah CG, Feder A, Charney DS, Grunebaum MF, Mann JJ, Mathew SJ, Gallagher B, ... ... Fava M, et al. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Molecular Psychiatry. PMID 36071111 DOI: 10.1038/s41380-022-01757-7 |
0.485 |
|
| 2022 |
Lee PH, Doyle AE, Silberstein M, Jung JY, Liu R, Perlis RH, Roffman J, Smoller JW, Fava M, Kessler RC. Associations Between Genetic Risk for Adult Suicide Attempt and Suicidal Behaviors in Young Children in the US. Jama Psychiatry. PMID 36044238 DOI: 10.1001/jamapsychiatry.2022.2379 |
0.529 |
|
| 2022 |
Mischoulon D, Dunlop BW, Kinkead B, Schettler PJ, Lamon-Fava S, Rakofsky JJ, Nierenberg AA, Clain AJ, Mletzko Crowe T, Wong A, Felger JC, Sangermano L, Ziegler TR, Cusin C, Fisher LB, ... Fava M, et al. Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. The Journal of Clinical Psychiatry. 83. PMID 36005883 DOI: 10.4088/JCP.21m14074 |
0.395 |
|
| 2022 |
Bloomfield-Clagett B, Ballard ED, Greenstein DK, Wilkinson ST, Grunebaum MF, Murrough JW, Mathew SJ, Phillips JL, Fava M, Sanacora G, Zarate CA. A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Non-Suicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. The International Journal of Neuropsychopharmacology. PMID 35994774 DOI: 10.1093/ijnp/pyac055 |
0.399 |
|
| 2022 |
Guidetti C, Serra G, Pani L, Pappagallo M, Maglio G, Trasolini M, De Martin S, Mattarei A, Bifari F, Folli F, Manfredi PL, Fava M. REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases. Journal of Clinical Psychopharmacology. PMID 35943402 DOI: 10.1097/JCP.0000000000001583 |
0.423 |
|
| 2022 |
Kim H, Choi J, Jeong B, Fava M, Mischoulon D, Park MJ, Kim HS, Jeon HJ. Impaired Oxygenation of the Prefrontal Cortex During Verbal Fluency Task in Young Adults With Major Depressive Disorder and Suicidality: A Functional Near-Infrared Spectroscopy Study. Frontiers in Psychiatry. 13: 915425. PMID 35815016 DOI: 10.3389/fpsyt.2022.915425 |
0.352 |
|
| 2022 |
Kim H, Yoo J, Han K, Lee DY, Fava M, Mischoulon D, Jeon HJ. Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study. Alzheimer's Research & Therapy. 14: 83. PMID 35710453 DOI: 10.1186/s13195-022-01026-3 |
0.369 |
|
| 2022 |
Iosifescu DV, Jones A, O'Gorman C, Streicher C, Feliz S, Fava M, Tabuteau H. Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI). The Journal of Clinical Psychiatry. 83. PMID 35649167 DOI: 10.4088/JCP.21m14345 |
0.42 |
|
| 2022 |
Harel EV, Shetreet E, Tennyson R, Fava M, Bar M. Constricted semantic relations in acute depression. Journal of Affective Disorders. PMID 35597474 DOI: 10.1016/j.jad.2022.05.100 |
0.61 |
|
| 2022 |
Kim HS, Pyo HJ, Fava M, Mischoulon D, Park MJ, Jeon HJ. Bullying, Psychological, and Physical Trauma During Early Life Increase Risk of Major Depressive Disorder in Adulthood: A Nationwide Community Sample of Korean Adults. Frontiers in Psychiatry. 13: 792734. PMID 35422720 DOI: 10.3389/fpsyt.2022.792734 |
0.351 |
|
| 2022 |
Trombello JM, Cooper CM, Fatt CC, Grannemann BD, Carmody TJ, Jha MK, Mayes TL, Greer TL, Yezhuvath U, Aslan S, Pizzagalli DA, Weissman MM, Webb CA, Dillon DG, McGrath PJ, ... Fava M, et al. Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial. Journal of Psychiatric Research. 149: 243-251. PMID 35290819 DOI: 10.1016/j.jpsychires.2022.03.015 |
0.414 |
|
| 2022 |
Park MJ, Yoo J, Han K, Shin DW, Fava M, Mischoulon D, Jeon HJ. High body weight variability is associated with increased risk of depression: a nationwide cohort study in South Korea. Psychological Medicine. 1-9. PMID 35257654 DOI: 10.1017/S003329172200040X |
0.37 |
|
| 2022 |
Feeney A, Hock RS, Fava M, Hernández Ortiz JM, Iovieno N, Papakostas GI. Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: A meta-analysis. Journal of Affective Disorders. 305: 55-64. PMID 35247482 DOI: 10.1016/j.jad.2022.02.074 |
0.396 |
|
| 2022 |
Sakurai H, Hoeppner B, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment. Journal of Clinical Psychopharmacology. 42: 140-145. PMID 35170480 DOI: 10.1097/JCP.0000000000001524 |
0.314 |
|
| 2022 |
Ang YS, Cusin C, Petibon Y, Dillon DG, Breiger M, Belleau EL, Normandin M, Schroder H, Boyden S, Hayden E, Levine MT, Jahan A, Meyer AK, Kang MS, Brunner D, ... ... Fava M, et al. A multi-pronged investigation of option generation using depression, PET and modafinil. Brain : a Journal of Neurology. PMID 35150243 DOI: 10.1093/brain/awab429 |
0.336 |
|
| 2022 |
Perlis RH, Fava M. Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again? Jama Psychiatry. PMID 35138341 DOI: 10.1001/jamapsychiatry.2021.4281 |
0.67 |
|
| 2021 |
Lee PH, Doyle AE, Li X, Silberstein M, Jung JY, Gollub RL, Nierenberg AA, Liu RT, Kessler RC, Perlis RH, Fava M. Genetic Association of Attention-Deficit/Hyperactivity Disorder and Major Depression With Suicidal Ideation and Attempts in Children: The Adolescent Brain Cognitive Development Study. Biological Psychiatry. PMID 35216811 DOI: 10.1016/j.biopsych.2021.11.026 |
0.586 |
|
| 2021 |
An JH, Han KD, Jung JH, Yoo J, Fava M, Mischoulon D, Jung SM, Shin DW, Hur KY, Jeon HJ. High Bodyweight Variability Increases Depression Risk in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study in Korea. Frontiers in Psychiatry. 12: 765129. PMID 34955919 DOI: 10.3389/fpsyt.2021.765129 |
0.412 |
|
| 2021 |
Fava M, Stahl S, Pani L, De Martin S, Pappagallo M, Guidetti C, Alimonti A, Bettini E, Mangano RM, Wessel T, de Somer M, Caron J, Vitolo OV, Gilbert A, Mehta H, et al. REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial. The American Journal of Psychiatry. appiajp202121020197. PMID 34933568 DOI: 10.1176/appi.ajp.2021.21020197 |
0.497 |
|
| 2021 |
Sakurai H, Norton RJ, Fisher LB, Nagaswami MV, Streeter CC, Meyer AK, Dean T, Fava M, Mischoulon D, Nyer MB. A Patient With Electroconvulsive Therapy-resistant Major Depressive Disorder With a Full Response to Heated Yoga: A Case Report. Journal of Psychiatric Practice. 27: 486-491. PMID 34768274 DOI: 10.1097/PRA.0000000000000587 |
0.503 |
|
| 2021 |
Loebel A, Koblan KS, Tsai J, Deng L, Fava M, Kent J, Hopkins SC. A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression. Journal of Affective Disorders. PMID 34614447 DOI: 10.1016/j.jad.2021.09.109 |
0.432 |
|
| 2021 |
Baek JH, Shin DW, Fava M, Mischoulon D, Kim H, Park MJ, Kim EJ, Han KD, Jeon HJ. Increased metabolic variability is associated with newly diagnosed depression: A nationwide cohort study. Journal of Affective Disorders. 294: 786-793. PMID 34375203 DOI: 10.1016/j.jad.2021.07.006 |
0.361 |
|
| 2021 |
Jo S, Baek IC, Fava M, Mischoulon D, Hong JP, Kim H, Park MJ, Kim EJ, Jeon HJ. Association of smartphone overuse with depression, anxiety, and other addictive behaviors: A nationwide community sample of Korean adults. Psychiatry Research. 304: 114133. PMID 34352593 DOI: 10.1016/j.psychres.2021.114133 |
0.42 |
|
| 2021 |
Iovieno N, Papakostas GI, Feeney A, Fava M, Mathew SJ, Iosifescu DI, Murrough JW, Macaluso M, Hock RS, Jha MK. Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset. The Journal of Clinical Psychiatry. 82. PMID 34133089 DOI: 10.4088/JCP.20r13682 |
0.474 |
|
| 2021 |
Kim H, Kim Y, Fava M, Mischoulon D, Shin MH, Lee DY, Jeon HJ. Increased risk of depression before and after unilateral or bilateral oophorectomy: A self-controlled case series study using a nationwide cohort in South Korea. Journal of Affective Disorders. 285: 47-54. PMID 33631480 DOI: 10.1016/j.jad.2021.02.003 |
0.414 |
|
| 2020 |
Chin Fatt CR, Cooper CM, Jha MK, Minhajuddin A, Rush AJ, Trombello JM, Fava M, McInnis M, Weissman M, Trivedi MH. Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder. Journal of Affective Disorders. 282: 602-610. PMID 33445082 DOI: 10.1016/j.jad.2020.12.102 |
0.455 |
|
| 2020 |
Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 164: 102219. PMID 33316626 DOI: 10.1016/j.plefa.2020.102219 |
0.349 |
|
| 2020 |
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-20. PMID 33289425 DOI: 10.1080/15622975.2020.1851052 |
0.511 |
|
| 2020 |
Jha MK, Fava M, Freeman MP, Thase ME, Papakostas GI, Shelton RC, Trivedi MH, Dirks B, Liu K, Stankovic S. Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder: Secondary Analysis From CLARITY. The Journal of Clinical Psychiatry. 82. PMID 33264819 DOI: 10.4088/JCP.20m13425 |
0.364 |
|
| 2020 |
Ang YS, Bruder GE, Keilp JG, Rutherford A, Alschuler DM, Pechtel P, Webb CA, Carmody T, Fava M, Cusin C, McGrath PJ, Weissman M, Parsey R, Oquendo MA, McInnis MG, et al. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine. 1-9. PMID 33213541 DOI: 10.1017/S0033291720004286 |
0.377 |
|
| 2020 |
Fava M, Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, Macaluso M, Morrison MF, Carpenter LL, Shelton R, Zajecka J, Papakostas GI. Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: e16-e24. PMID 33125454 DOI: 10.12788/acp.0003 |
0.335 |
|
| 2020 |
Jha MK, Fava M, Minhajuddin A, Chin Fatt C, Mischoulon D, Cusin C, Trivedi MH. Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study. Depression and Anxiety. PMID 33038902 DOI: 10.1002/da.23095 |
0.401 |
|
| 2020 |
Chin Fatt CR, Cooper C, Jha MK, Aslan S, Grannemann B, Kurian B, Greer TL, Fava M, Weissman M, McGrath PJ, Parsey RV, Etkin A, Phillips ML, Trivedi MH. Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32921587 DOI: 10.1016/J.Bpsc.2020.06.019 |
0.524 |
|
| 2020 |
Sakurai H, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review. Journal of Affective Disorders. 276: 660-666. PMID 32871698 DOI: 10.1016/J.Jad.2020.07.089 |
0.43 |
|
| 2020 |
Shelton RC, Fava M, Freeman MP, Thase ME, Papakostas GI, Jha MK, Trivedi MH, Dirks B, Liu K, Stankovic S. Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study. Journal of Affective Disorders. 277: 478-485. PMID 32871535 DOI: 10.1016/j.jad.2020.08.051 |
0.484 |
|
| 2020 |
Papakostas GI, Fava M, Freeman MP, Shelton RC, Thase ME, Jha MK, Trivedi MH, Dirks B, Liu K, Stankovic S. Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study. International Clinical Psychopharmacology. PMID 32804742 DOI: 10.1097/YIC.0000000000000328 |
0.536 |
|
| 2020 |
Johe KK, Kay G, Kumar S, Burdick KE, McIntyre RS, Papakostas GI, Fava M. NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: 182-196. PMID 32722729 |
0.484 |
|
| 2020 |
Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld DA, Fisher L, Cusin C, Dording C, Trinh NH, Pedrelli P, Yeung A, Farabaugh A, ... ... Fava M, et al. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844. PMID 32660299 DOI: 10.1176/Appi.Ajp.2020.19080844 |
0.532 |
|
| 2020 |
Dichtel LE, Nyer M, Dording C, Fisher LB, Cusin C, Shapero BG, Pedrelli P, Kimball AS, Rao EM, Mischoulon D, Fava M, Miller KK. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study. The Journal of Clinical Psychiatry. 81. PMID 32558402 DOI: 10.4088/Jcp.19M12887 |
0.506 |
|
| 2020 |
Kamiya M, Sabia HD, Marella J, Fava M, Nemeroff CB, Umeuchi H, Iijima M, Chaki S, Nishino I. Efficacy and safety of TS-121, a novel vasopressin V receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study. Journal of Psychiatric Research. 128: 43-51. PMID 32521250 DOI: 10.1016/j.jpsychires.2020.05.017 |
0.496 |
|
| 2020 |
An JH, Park MJ, Fava M, Mischoulon D, Kim H, Jang J, Hong JP, Park JS, Jeon HJ. Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia. Frontiers in Psychiatry. 11: 444. PMID 32508689 DOI: 10.3389/fpsyt.2020.00444 |
0.472 |
|
| 2020 |
Ang YS, Kaiser R, Deckersbach T, Almeida J, Phillips ML, Chase HW, Webb CA, Parsey R, Fava M, McGrath P, Weissman M, Adams P, Deldin P, Oquendo MA, McInnis MG, et al. Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. Biological Psychiatry. PMID 32507389 DOI: 10.1016/J.Biopsych.2020.04.009 |
0.43 |
|
| 2020 |
Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, Iosifescu DV, Fava M. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis. The Journal of Clinical Psychiatry. 81. PMID 32459407 DOI: 10.4088/Jcp.19R12889 |
0.575 |
|
| 2020 |
Perlis RH, Dowd D, Fava M, Lencz T, Krause DS. Randomized, controlled, participant- and rater-blind trial of pharmacogenomic test-guided treatment versus treatment as usual for major depressive disorder. Depression and Anxiety. PMID 32383277 DOI: 10.1002/da.23029 |
0.697 |
|
| 2020 |
Freeman MP, Hock RS, Papakostas GI, Judge H, Cusin C, Mathew SJ, Sanacora G, Iosifescu DV, DeBattista C, Trivedi MH, Fava M. Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder. Journal of Clinical Psychopharmacology. 40: 287-292. PMID 32332464 DOI: 10.1097/Jcp.0000000000001209 |
0.539 |
|
| 2020 |
Fava M, Dirks B, Freeman MP, Shelton RC, Thase ME, Trivedi MH, Papakostas GI, Liu K, Whitworth T, Stankovic S. 181 A Phase-2 Sequential Parallel Comparison Design Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder. Cns Spectrums. 25: 314-315. PMID 32331041 DOI: 10.1017/S1092852920000966 |
0.589 |
|
| 2020 |
Freeman MP, Fava M, Dirks B, Jha MK, Shelton RC, Thase ME, Trivedi MH, Papakostas GI, Liu K, Whitworth T, Stankovic S. 180 Improvement of Sexual Function Observed During Treatment of Major Depressive Disorder with Adjunctive Pimavanserin. Cns Spectrums. 25: 313-314. PMID 32331034 DOI: 10.1017/S1092852920000954 |
0.5 |
|
| 2020 |
Freeman MP, Fava M, Dirks B, Jha MK, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S. Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis. Depression and Anxiety. PMID 32301591 DOI: 10.1002/da.23017 |
0.401 |
|
| 2020 |
Wu W, Zhang Y, Jiang J, Lucas MV, Fonzo GA, Rolle CE, Cooper C, Chin-Fatt C, Krepel N, Cornelssen CA, Wright R, Toll RT, Trivedi HM, Monuszko K, Caudle TL, ... ... Fava M, et al. An electroencephalographic signature predicts antidepressant response in major depression. Nature Biotechnology. PMID 32042166 DOI: 10.1038/S41587-019-0397-3 |
0.518 |
|
| 2020 |
Salloum NC, Fava M, Ball S, Papakostas GI. Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review. Molecular Psychiatry. PMID 31988433 DOI: 10.1038/s41380-020-0646-3 |
0.38 |
|
| 2020 |
Kim H, Kim Y, Baek JH, Fava M, Mischoulon D, Nierenberg AA, Choi KW, Na EJ, Shin MH, Jeon HJ. Predictive factors of diagnostic conversion from major depressive disorder to bipolar disorder in young adults ages 19-34: A nationwide population study in South Korea. Journal of Affective Disorders. 265: 52-58. PMID 31957692 DOI: 10.1016/j.jad.2020.01.009 |
0.459 |
|
| 2020 |
Rolle CE, Fonzo GA, Wu W, Toll R, Jha MK, Cooper C, Chin-Fatt C, Pizzagalli DA, Trombello JM, Deckersbach T, Fava M, Weissman MM, Trivedi MH, Etkin A. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial. Jama Psychiatry. PMID 31895437 DOI: 10.1001/Jamapsychiatry.2019.3867 |
0.462 |
|
| 2020 |
Dichtel LE, Nyer M, Dording C, Fisher LB, Cusin C, Shapero BG, Pedrelli P, Kimball A, Rao EM, Mischoulon D, Fava M, Miller KK. SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.082 |
0.553 |
|
| 2020 |
Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld D, Fisher L, Cusin C, Trinh N, Pedrelli P, Yeung A, Farabaugh A, Papakostas G, ... ... Fava M, et al. SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.081 |
0.499 |
|
| 2020 |
Ang Y, Keilp J, Webb C, Dillon D, Deldin P, Alschuler D, Alvarenga J, McGrath P, Weissman M, Parsey R, Fava M, Trivedi M, Bruder G, Pizzagalli D. Cognitive Subtypes of Depression are Associated With Response to Treatment by Sertraline Biological Psychiatry. 87: S374. DOI: 10.1016/J.Biopsych.2020.02.957 |
0.485 |
|
| 2020 |
Jha M, Fava M, Minhajuddin A, Fatt CC, Mischoulon D, Cusin C, Trivedi M. Association of Anger Attacks With Persistently Elevated Suicidality in Depressed Patients: Do Early Improvements in Irritability Reduce the Risk? Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.298 |
0.478 |
|
| 2020 |
Cooper C, Trombello J, Chin Fatt C, Patem E, Fava M, McGrath P, Parsey R, Weissman M, Phillips M, Lu H, Trivedi M. Characterizing Cerebral Blood Perfusion and Treatment Outcomes in Atypical and Melancholic Depression Biological Psychiatry. 87: S94. DOI: 10.1016/J.Biopsych.2020.02.261 |
0.469 |
|
| 2020 |
Jha M, Fava M, Minhajuddin A, Fatt CC, Mischoulon D, Wakhlu N, Trombello J, Cusin C, Trivedi M. Neural Circuits Linking Irritability and Anger Attacks in Major Depressive Disorder: Findings From EMBARC Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.208 |
0.52 |
|
| 2020 |
Rapaport M, Mischoulon D, Fava M, Dunlop B, Kinkead B, Felger J, Nierenberg A, Schettler P, Lamon-Fava S. Does n-3 Fatty Acid Supplementation Impact Immune and Clinical Outcomes in Inflammatory Depression? Biological Psychiatry. 87: S40. DOI: 10.1016/J.Biopsych.2020.02.126 |
0.402 |
|
| 2019 |
Barbour T, Holmes AJ, Farabaugh AH, DeCross SN, Coombs G, Boeke EA, Wolthusen RPF, Nyer M, Pedrelli P, Fava M, Holt DJ. Elevated Amygdala Activity in Young Adults With Familial Risk for Depression: A Potential Marker of Low Resilience. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31948836 DOI: 10.1016/J.Bpsc.2019.10.010 |
0.523 |
|
| 2019 |
Baker A, Simon N, Keshaviah A, Farabaugh A, Deckersbach T, Worthington JJ, Hoge E, Fava M, Pollack MP. Anxiety Symptoms Questionnaire (ASQ): development and validation. General Psychiatry. 32: e100144. PMID 31922090 DOI: 10.1136/gpsych-2019-100144 |
0.315 |
|
| 2019 |
Pedrelli P, Fisher LB, Nyer M, Shapero BG, Farabaugh A, Hayden ER, Levine MT, Fava M, Weiss RD, Borsari B, Merrill JE. Evaluating the combination of a Brief Motivational Intervention plus Cognitive Behavioral Therapy for Depression and heavy episodic drinking in college students. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 31855009 DOI: 10.1037/Adb0000538 |
0.487 |
|
| 2019 |
Sakurai H, L Carpenter L, R Tyrka A, Price LH, I Papakostas G, Dording CM, Yeung AS, Cusin C, Ludington E, Bernard-Negron R, Fava M, Mischoulon D. Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder. Journal of Affective Disorders. 262: 118-125. PMID 31733455 DOI: 10.1016/J.Jad.2019.10.040 |
0.488 |
|
| 2019 |
Kim K, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim H, Na EJ, Yu HY, Jeon HJ. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study. Comprehensive Psychiatry. 95: 152140. PMID 31669792 DOI: 10.1016/j.comppsych.2019.152140 |
0.528 |
|
| 2019 |
Kim H, Kim Y, Myung W, Fava M, Mischoulon D, Lee U, Lee H, Jin Na E, Woo Choi K, Shin MH, Jin Jeon H. Risks of suicide attempts after prescription of zolpidem in people with depression: A nationwide population study in South Korea. Sleep. PMID 31586200 DOI: 10.1093/sleep/zsz235 |
0.479 |
|
| 2019 |
Fava M, Dirks B, Freeman MP, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY). The Journal of Clinical Psychiatry. 80. PMID 31556975 DOI: 10.4088/JCP.19m12928 |
0.506 |
|
| 2019 |
Fonzo GA, Etkin A, Zhang Y, Wu W, Cooper C, Chin-Fatt C, Jha MK, Trombello J, Deckersbach T, Adams P, McInnis M, McGrath PJ, Weissman MM, Fava M, Trivedi MH. Brain regulation of emotional conflict predicts antidepressant treatment response for depression. Nature Human Behaviour. PMID 31548678 DOI: 10.1038/S41562-019-0732-1 |
0.439 |
|
| 2019 |
Chin Fatt CR, Jha MK, Cooper CM, Fonzo G, South C, Grannemann B, Carmody T, Greer TL, Kurian B, Fava M, McGrath PJ, Adams P, McInnis M, Parsey RV, Weissman M, et al. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression. The American Journal of Psychiatry. appiajp201918070870. PMID 31537090 DOI: 10.1176/Appi.Ajp.2019.18070870 |
0.451 |
|
| 2019 |
Na EJ, Choi KW, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Paranoid Ideation Without Psychosis Is Associated With Depression, Anxiety, and Suicide Attempts in General Population. The Journal of Nervous and Mental Disease. PMID 31503180 DOI: 10.1097/NMD.0000000000001050 |
0.439 |
|
| 2019 |
Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression. Journal of Affective Disorders. 260: 131-139. PMID 31494365 DOI: 10.1016/J.Jad.2019.09.017 |
0.517 |
|
| 2019 |
An JH, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Na EJ, Jang J, Yu HY, Hong JP, Jeon HJ. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study. Journal of Affective Disorders. 259: 349-354. PMID 31465895 DOI: 10.1016/j.jad.2019.08.021 |
0.507 |
|
| 2019 |
Greenberg T, Fournier JC, Stiffler R, Chase HW, Almeida JR, Aslam H, Deckersbach T, Cooper C, Toups MS, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, Oquendo MA, ... Fava M, et al. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals. Molecular Psychiatry. PMID 31462766 DOI: 10.1038/S41380-019-0490-5 |
0.485 |
|
| 2019 |
Choi KW, Kim Y, Fava M, Mischoulon D, Na EJ, Kim SW, Shin MH, Chung MK, Jeon HJ. Increased morbidity of major depressive disorder after thyroidectomy: a nationwide population-based study in South Korea. Thyroid : Official Journal of the American Thyroid Association. PMID 31422760 DOI: 10.1089/thy.2019.0091 |
0.404 |
|
| 2019 |
Sakurai H, Dording C, Yeung A, Foster S, Jain F, Chang T, Trinh NH, Bernard R, Boyden S, Iqbal SZ, Wilkinson ST, Mathew SJ, Mischoulon D, Fava M, Cusin C. Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. Journal of Affective Disorders. 258: 102-108. PMID 31400624 DOI: 10.1016/j.jad.2019.06.065 |
0.508 |
|
| 2019 |
Gomeni R, Rabinowitz J, Goyal N, Bressolle-Gomeni FMM, Fava M. Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo Response. Clinical Pharmacology and Therapeutics. PMID 31397904 DOI: 10.1002/cpt.1584 |
0.306 |
|
| 2019 |
Cooper CM, Chin Fatt CR, Liu P, Grannemann BD, Carmody T, Almeida JRC, Deckersbach T, Fava M, Kurian BT, Malchow AL, McGrath PJ, McInnis M, Oquendo MA, Parsey RV, Bartlett E, et al. Discovery and replication of cerebral blood flow differences in major depressive disorder. Molecular Psychiatry. PMID 31388104 DOI: 10.1038/S41380-019-0464-7 |
0.403 |
|
| 2019 |
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, et al. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). The International Journal of Neuropsychopharmacology. PMID 31290965 DOI: 10.1093/Ijnp/Pyz039 |
0.55 |
|
| 2019 |
Nyer M, Hopkins LB, Farabaugh A, Nauphal M, Parkin S, McKee MM, Miller KK, Streeter C, Uebelacker LA, Fava M, Alpert JE, Pedrelli P, Mischoulon D. Community-Delivered Heated Hatha Yoga as a Treatment for Depressive Symptoms: An Uncontrolled Pilot Study. Journal of Alternative and Complementary Medicine (New York, N.Y.). PMID 31290694 DOI: 10.1089/Acm.2018.0365 |
0.728 |
|
| 2019 |
Thase ME, Stanford AD, Memisoglu A, Martin W, Claxton A, Alexander Bodkin J, Trivedi MH, Fava M, Yu M, Pathak S. Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31254971 DOI: 10.1038/S41386-019-0451-3 |
0.532 |
|
| 2019 |
Cooper CM, Chin Fatt CR, Jha M, Fonzo GA, Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach T, Fava M, Kurian BT, McGrath PJ, McInnis M, Parsey RV, et al. Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial. Eclinicalmedicine. 10: 32-41. PMID 31193824 DOI: 10.1016/J.Eclinm.2019.04.007 |
0.486 |
|
| 2019 |
Meichen Y, Linn KA, Shinohara RT, Oathes DJ, Cook PA, Duprat R, Moore TM, Oquendo MA, Phillips ML, McInnis M, Fava M, Trivedi MH, McGrath P, Parsey R, Weissman MM, et al. Correction: Childhood trauma history is linked to abnormal brain connectivity in major depression (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (8582–8590) DOI: 10.1073/pnas.1900801116) Proceedings of the National Academy of Sciences of the United States of America. 116. PMID 31182599 DOI: 10.1073/Pnas.1908918116 |
0.401 |
|
| 2019 |
Pillai RLI, Huang C, LaBella A, Zhang M, Yang J, Trivedi M, Weissman M, McGrath P, Fava M, Kurian B, Cooper C, McInnis M, Oquendo MA, Pizzagalli DA, Parsey RV, et al. Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response. Journal of Affective Disorders. 256: 8-16. PMID 31158720 DOI: 10.1016/J.Jad.2019.05.055 |
0.427 |
|
| 2019 |
Kim K, Shin JH, Myung W, Fava M, Mischoulon D, Papakostas GI, Choi KW, Na EJ, Seo SW, Seong JK, Jeon HJ. Deformities of the Globus Pallidus are Associated with Severity of Suicidal Ideation and Impulsivity in Patients with Major Depressive Disorder. Scientific Reports. 9: 7462. PMID 31097766 DOI: 10.1038/s41598-019-43882-4 |
0.415 |
|
| 2019 |
Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry. PMID 30916714 DOI: 10.1001/Jamapsychiatry.2019.0151 |
0.599 |
|
| 2019 |
Thase M, Stanford AD, Memisoglu A, Martin W, Claxton A, Bodnik JA, Trivedi MH, Fava M, Pathak S. 50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results. Cns Spectrums. 24: 203-204. PMID 30859977 DOI: 10.1017/S1092852919000427 |
0.511 |
|
| 2019 |
Biederman J, Lindsten A, Sluth LB, Petersen ML, Ettrup A, Eriksen HF, Fava M. Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study. Journal of Psychopharmacology (Oxford, England). 269881119832538. PMID 30843450 DOI: 10.1177/0269881119832538 |
0.31 |
|
| 2019 |
Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Comparison of suicide attempts in individuals with major depressive disorder with and without history of subthreshold hypomania: A nationwide community sample of Korean adults. Journal of Affective Disorders. 248: 18-25. PMID 30710859 DOI: 10.1016/j.jad.2019.01.022 |
0.53 |
|
| 2019 |
Liao A, Walker R, Carmody TJ, Cooper C, Shaw MA, Grannemann BD, Adams P, Bruder GE, McInnis MG, Webb CA, Dillon DG, Pizzagalli DA, Phillips ML, Kurian BT, Fava M, et al. Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control. Journal of Affective Disorders. 245: 1070-1078. PMID 30699849 DOI: 10.1016/J.Jad.2018.11.072 |
0.523 |
|
| 2019 |
Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M. Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression. Journal of Psychiatric Research. 110: 166-171. PMID 30641350 DOI: 10.1016/J.Jpsychires.2019.01.010 |
0.456 |
|
| 2019 |
Papakostas GI, Johe K, Hand H, Drouillard A, Russo P, Kay G, Kashambwa R, Hoeppner B, Flynn M, Yeung A, Martinson MA, Fava M. A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder. Molecular Psychiatry. PMID 30626911 DOI: 10.1038/S41380-018-0334-8 |
0.462 |
|
| 2019 |
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30617276 DOI: 10.1038/S41380-018-0311-2 |
0.425 |
|
| 2019 |
Dichtel L, Kimball A, Nyer M, Mischoulon D, Fisher L, Cusin C, Dording C, Trinh N, Yeung A, Rao E, Pinna G, Carpenter L, Fava M, Miller K. MON-449 Serum Neuroactive Steroid Levels in Postmenopausal Women with Treatment-Resistant Major Depressive Disorder Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-449 |
0.482 |
|
| 2019 |
Cooper CM, Fatt CRC, Jha M, Fonzo G, Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach T, Fava M, Kurian BT, McGrath PJ, McInnis M, Parsey RV, et al. Cerebral Blood Perfusion Moderates Treatment Response to Sertraline in Major Depressive Disorder Journal of Affective Disorders. 254: 137. DOI: 10.1016/J.Jad.2018.10.302 |
0.529 |
|
| 2019 |
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele Hvd, Manjii H, Hough D, et al. Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression Journal of Affective Disorders. 254: 131-132. DOI: 10.1016/J.Jad.2018.10.289 |
0.488 |
|
| 2019 |
Cooper C, Fatt CC, Jha M, Fonzo G, Grannemann B, Carmody T, Ali A, Aslan S, Almeida J, Deckersbach T, Fava M, Kurian B, McGrath P, McInnis M, Parsey R, et al. O14. Cerebral Blood Perfusion Predicts Response to Antidepressant Treatment in Major Depressive Disorder Biological Psychiatry. 85: S111. DOI: 10.1016/J.Biopsych.2019.03.279 |
0.497 |
|
| 2018 |
Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Focus (American Psychiatric Publishing). 16: 328-340. PMID 32015713 DOI: 10.1176/appi.focus.16304 |
0.393 |
|
| 2018 |
Whitton AE, Webb CA, Dillon DG, Kayser J, Rutherford A, Goer F, Fava M, McGrath P, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, et al. Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial. Biological Psychiatry. PMID 30718038 DOI: 10.1016/J.Biopsych.2018.12.007 |
0.453 |
|
| 2018 |
Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depression and Anxiety. PMID 30597688 DOI: 10.1002/Da.22875 |
0.541 |
|
| 2018 |
Choi KW, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim DJ, Kim K, Yu HY, Jeon HJ. Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study. Journal of Affective Disorders. 246: 157-165. PMID 30583140 DOI: 10.1016/j.jad.2018.12.048 |
0.475 |
|
| 2018 |
Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M. Tachyphylaxis in major depressive disorder: A review of the current state of research. Journal of Affective Disorders. 245: 488-497. PMID 30439676 DOI: 10.1016/j.jad.2018.10.357 |
0.558 |
|
| 2018 |
Perlis RH, Fava M, McCoy TH. Can electronic health records revive central nervous system clinical trials? Molecular Psychiatry. PMID 30429581 DOI: 10.1038/s41380-018-0278-z |
0.562 |
|
| 2018 |
Shapero BG, Farabaugh A, Terechina O, DeCross S, Cheung JC, Fava M, Holt DJ. Understanding the effects of emotional reactivity on depression and suicidal thoughts and behaviors: Moderating effects of childhood adversity and resilience. Journal of Affective Disorders. 245: 419-427. PMID 30423470 DOI: 10.1016/j.jad.2018.11.033 |
0.444 |
|
| 2018 |
Fava M, Thase ME, Trivedi MH, Ehrich E, Martin WF, Memisoglu A, Nangia N, Stanford AD, Yu M, Pathak S. Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies. Molecular Psychiatry. PMID 30374191 DOI: 10.1038/s41380-018-0284-1 |
0.457 |
|
| 2018 |
Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, ... ... Fava M, et al. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomedicine and Laser Surgery. PMID 30346890 DOI: 10.1089/Pho.2018.4490 |
0.757 |
|
| 2018 |
Ionescu DF, Bentley KH, Eikermann M, Taylor N, Johnson-Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, et al. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Journal of Affective Disorders. 243: 516-524. PMID 30286416 DOI: 10.1016/J.Jad.2018.09.037 |
0.724 |
|
| 2018 |
Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. PMID 30283029 DOI: 10.1038/S41380-018-0256-5 |
0.379 |
|
| 2018 |
Kim H, Choi KW, Na EJ, Hong JP, Fava M, Mischoulon D, Cho H, Jeon HJ. Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adults. Psychiatry Research. 270: 257-263. PMID 30273856 DOI: 10.1016/j.psychres.2018.09.050 |
0.455 |
|
| 2018 |
Choi KW, Na EJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder. Psychiatry Research. 270: 246-252. PMID 30269042 DOI: 10.1016/j.psychres.2018.09.047 |
0.578 |
|
| 2018 |
Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression. Frontiers in Psychiatry. 9: 424. PMID 30245644 DOI: 10.3389/Fpsyt.2018.00424 |
0.558 |
|
| 2018 |
Shapero BG, Gibb BE, Archibald A, Wilens TE, Fava M, Hirshfeld-Becker DR. Risk Factors for Depression in Adolescents With ADHD: The Impact of Cognitive Biases and Stress. Journal of Attention Disorders. 1087054718797447. PMID 30198368 DOI: 10.1177/1087054718797447 |
0.493 |
|
| 2018 |
Ulke C, Tenke CE, Kayser J, Sander C, Böttger D, Wong LYX, Alvarenga JE, Fava M, McGrath PJ, Deldin PJ, Mcinnis MG, Trivedi MH, Weissman MM, Pizzagalli DA, Hegerl U, et al. Resting EEG Measures of Brain Arousal in a Multisite Study of Major Depression. Clinical Eeg and Neuroscience. 1550059418795578. PMID 30182751 DOI: 10.1177/1550059418795578 |
0.468 |
|
| 2018 |
Yang J, Zhang M, Ahn H, Zhang Q, Jin TB, Li IA, Nemesure M, Joshi N, Jiang H, Miller JM, Ogden RT, Petkova E, Milak MS, Sublette ME, Sullivan GM, ... ... Fava M, et al. Development and evaluation of a multimodal marker of major depressive disorder. Human Brain Mapping. PMID 30113112 DOI: 10.1002/Hbm.24282 |
0.49 |
|
| 2018 |
Trivedi MH, South C, Jha MK, Rush AJ, Cao J, Kurian B, Phillips M, Pizzagalli DA, Trombello JM, Oquendo MA, Cooper C, Dillon DG, Webb C, Grannemann BD, Bruder G, ... ... Fava M, et al. A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial. Psychotherapy and Psychosomatics. 1-11. PMID 30110685 DOI: 10.1159/000491093 |
0.402 |
|
| 2018 |
Fava M, Durgam S, Earley W, Lu K, Hayes R, Laszlovszky I, Németh G. Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial. International Clinical Psychopharmacology. PMID 30045066 DOI: 10.1097/YIC.0000000000000235 |
0.508 |
|
| 2018 |
Webb CA, Trivedi MH, Cohen ZD, Dillon DG, Fournier JC, Goer F, Fava M, McGrath PJ, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, et al. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study. Psychological Medicine. 1-10. PMID 29962359 DOI: 10.1017/S0033291718001708 |
0.562 |
|
| 2018 |
Bartlett EA, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath PJ, Fava M, Ogden RT, Kurian BT, Malchow A, Cooper CM, Trombello JM, McInnis M, et al. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29955151 DOI: 10.1038/S41386-018-0122-9 |
0.442 |
|
| 2018 |
Pedrelli P, MacPherson L, Khan AJ, Shapero BG, Fisher LB, Nyer M, Cassano P, Parnarouskis L, Farabaugh A, Fava M, Silveri MM. Sex Differences in the Association between Heavy Drinking and Behavioral Distress Tolerance and Emotional Reactivity Among Non-Depressed College Students. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29947730 DOI: 10.1093/Alcalc/Agy045 |
0.342 |
|
| 2018 |
Baek JH, Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Chang SM, Kim JY, Cho H, Jeon HJ. Binge eating, trauma, and suicide attempt in community adults with major depressive disorder. Plos One. 13: e0198192. PMID 29927937 DOI: 10.1371/journal.pone.0198192 |
0.44 |
|
| 2018 |
Curren L, Huz I, McKee M, Traeger L, Bedoya CA, Chang TE, Cassano P, Fava M, Alpert J, Yeung A, Gilman SE, Trinh NH. Patient primary language in a culturally focused intervention for Latino Americans with depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 30: 84-90. PMID 29697708 |
0.344 |
|
| 2018 |
Trombello JM, Pizzagalli DA, Weissman MM, Grannemann BD, Cooper CM, Greer TL, Malchow AL, Jha MK, Carmody TJ, Kurian BT, Webb CA, Dillon DG, McGrath PJ, Bruder G, Fava M, et al. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study. Journal of Psychiatric Research. 102: 207-215. PMID 29689518 DOI: 10.1016/J.Jpsychires.2018.04.003 |
0.496 |
|
| 2018 |
Pizzagalli DA, Webb CA, Dillon DG, Tenke CE, Kayser J, Goer F, Fava M, McGrath P, Weissman M, Parsey R, Adams P, Trombello J, Cooper C, Deldin P, Oquendo MA, et al. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial. Jama Psychiatry. PMID 29641834 DOI: 10.1001/Jamapsychiatry.2018.0252 |
0.482 |
|
| 2018 |
Nyer M, Gerbarg PL, Silveri MM, Johnston J, Scott TM, Nauphal M, Owen L, Nielsen GH, Mischoulon D, Brown RP, Fava M, Streeter CC. A randomized controlled dosing study of Iyengar yoga and coherent breathing for the treatment of major depressive disorder: Impact on suicidal ideation and safety findings. Complementary Therapies in Medicine. 37: 136-142. PMID 29609926 DOI: 10.1016/J.Ctim.2018.02.006 |
0.478 |
|
| 2018 |
Vance MC, Bui E, Hoeppner SS, Kovachy B, Prescott J, Mischoulon D, Walton ZE, Dong M, Nadal MF, Worthington JJ, Hoge EA, Cassano P, Orr EH, Fava M, de Vivo I, et al. Prospective association between major depressive disorder and leukocyte telomere length over two years. Psychoneuroendocrinology. 90: 157-164. PMID 29499556 DOI: 10.1016/J.Psyneuen.2018.02.015 |
0.511 |
|
| 2018 |
Gomeni R, Bressolle-Gomeni F, Fava M. Is It Time for Going Beyond the P-Value Paradigm With the Estimation of the Probability of Clinical Benefit as a Criterion for Assessing the Outcomes of a Clinical Trial? A Case Study in Patients With Major Depressive Disorder. Journal of Clinical Pharmacology. PMID 29372561 DOI: 10.1002/jcph.1074 |
0.462 |
|
| 2018 |
Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M. Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies. Neuropsychiatric Disease and Treatment. 14: 103-115. PMID 29343962 DOI: 10.2147/NDT.S146840 |
0.545 |
|
| 2018 |
Rybin D, Lew R, Pencina MJ, Fava M, Doros G. Placebo Response as a Latent Characteristic: Application to Analysis of Sequential Parallel Comparison Design Studies Journal of the American Statistical Association. 113: 1411-1430. DOI: 10.1080/01621459.2017.1375930 |
0.314 |
|
| 2018 |
South C, Jha M, Rush AJ, Cao J, Cooper C, Trombello J, Phillips ML, Carmody T, Parsey R, Oquendo MA, McGrath P, Bruder G, Tenke CE, Weissman M, Pizzagalli D, ... ... Fava M, et al. S107. Identifying Characteristics of Placebo Responders in Major Depression From the EMBARC Study Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.998 |
0.545 |
|
| 2018 |
Kayser J, Tenke CE, Petkova E, Wong LY, Wickramaratne P, Alschuler DM, Alvarenga JE, Abraham K, Pechtel P, Webb CA, Dillon DG, Deldin P, Cooper C, Trombello J, McGrath P, ... Fava M, et al. S95. Loudness Dependency of Auditory Evoked Potentials (LDAEP) as a Differential Predictor of Antidepressant Treatment Response in Major Depressive Disorder (MDD): Results From the Sertraline/Placebo-Controlled EMBARC Study Biological Psychiatry. 83: S383-S384. DOI: 10.1016/J.Biopsych.2018.02.986 |
0.544 |
|
| 2018 |
Bartlett E, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath P, Fava M, Ogden T, Kurian B, Malchow A, Cooper C, Trombello J, McInnis M, et al. 176. Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder Biological Psychiatry. 83: S71. DOI: 10.1016/J.Biopsych.2018.02.194 |
0.53 |
|
| 2018 |
Cooper C, Fatt CC, Fonzo G, Jha M, Grannemann B, Aslan S, Almeida J, Deckersbach T, Fava M, Kurian B, McGrath P, McInnis M, Parsey R, Weissman M, Phillips M, et al. S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive Disorder Biological Psychiatry. 83: S399. DOI: 10.1016/J.Biopsych.2018.02.1023 |
0.515 |
|
| 2018 |
Fatt CC, Cooper C, Jha M, Fonzo G, Grannemann B, Aslan S, Greer T, Fava M, Phillips M, McGrath P, Adams P, Weissman M, Kurian B, Parsey R, McInnis M, et al. S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive Disorder Biological Psychiatry. 83: S398-S399. DOI: 10.1016/J.Biopsych.2018.02.1022 |
0.505 |
|
| 2018 |
Farabaugh A, Nyer MB, Holt DJ, Fisher LB, Cheung JC, Anton J, Petrie SR, Pedrelli P, Bentley K, Shapero BG, Baer L, Fava M, Mischoulon D. CBT Delivered in a Specialized Depression Clinic for College Students with Depressive Symptoms Journal of Rational-Emotive & Cognitive-Behavior Therapy. 37: 52-61. DOI: 10.1007/S10942-018-0300-Z |
0.554 |
|
| 2017 |
Kim K, Kim SW, Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Seo SW, Cho H, Seong JK, Jeon HJ. Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder. Scientific Reports. 7: 15772. PMID 29150619 DOI: 10.1038/S41598-017-15926-0 |
0.389 |
|
| 2017 |
Yeung A, Wang F, Feng F, Zhang J, Cooper A, Hong L, Wang W, Griffiths K, Bennett K, Bennett A, Alpert J, Fava M. Outcomes of an online computerized cognitive behavioral treatment program for treating chinese patients with depression: A pilot study. Asian Journal of Psychiatry. PMID 29146042 DOI: 10.1016/J.Ajp.2017.11.007 |
0.665 |
|
| 2017 |
Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Alcohol-induced disinhibition is associated with impulsivity, depression, and suicide attempt: A nationwide community sample of Korean adults. Journal of Affective Disorders. 227: 323-329. PMID 29132075 DOI: 10.1016/j.jad.2017.11.001 |
0.305 |
|
| 2017 |
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. Journal of Affective Disorders. 227: 198. PMID 29100152 DOI: 10.1016/J.Jad.2017.10.040 |
0.686 |
|
| 2017 |
Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, et al. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimulation. PMID 29030111 DOI: 10.1016/J.Brs.2017.09.010 |
0.472 |
|
| 2017 |
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-19. PMID 28984491 DOI: 10.1080/15622975.2017.1379609 |
0.535 |
|
| 2017 |
Fournier JC, Chase HW, Greenberg T, Etkin A, Almeida JR, Stiffler R, Deckersbach T, Weyandt S, Cooper C, Toups M, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, ... ... Fava M, et al. Neuroticism and Individual Differences in Neural Function in Unmedicated Major Depression: Findings from the EMBARC Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 138-148. PMID 28983519 DOI: 10.1016/J.Bpsc.2016.11.008 |
0.563 |
|
| 2017 |
Griffiths CEM, Fava M, Miller AH, Russell J, Ball SG, Xu W, Acharya N, Rapaport MH. Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies. Psychotherapy and Psychosomatics. 86: 260-267. PMID 28903122 DOI: 10.1159/000479163 |
0.495 |
|
| 2017 |
Bui E, Fava M. From depression to anxiety, and back. Acta Psychiatrica Scandinavica. PMID 28865404 DOI: 10.1111/Acps.12801 |
0.55 |
|
| 2017 |
Heo JY, Yi H, Fava M, Mischoulon D, Kim K, Yoon S, Jeon HJ, Lee JE. Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study. Psychiatry Investigation. 14: 491-498. PMID 28845177 DOI: 10.4306/pi.2017.14.4.491 |
0.387 |
|
| 2017 |
Iovieno N, Shelton RC, Petrie SR, Cusin C, Fava M, Papakostas GI. Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder. The Journal of Clinical Psychiatry. PMID 28749091 DOI: 10.4088/JCP.16m10920 |
0.507 |
|
| 2017 |
Fava M. Lessons Learned From the VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D) Study. Jama. 318: 126-128. PMID 28697241 DOI: 10.1001/jama.2017.8030 |
0.443 |
|
| 2017 |
Yuan H, Mischoulon D, Fava M, Otto MW. Circulating microRNAs as biomarkers for depression: Many candidates, few finalists. Journal of Affective Disorders. PMID 28673667 DOI: 10.1016/j.jad.2017.06.058 |
0.508 |
|
| 2017 |
Petkova E, Ogden RT, Tarpey T, Ciarleglio A, Jiang B, Su Z, Carmody T, Adams P, Kraemer HC, Grannemann BD, Oquendo MA, Parsey R, Weissman M, McGrath PJ, Fava M, et al. Statistical Analysis Plan for Stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) Study. Contemporary Clinical Trials Communications. 6: 22-30. PMID 28670629 DOI: 10.1016/J.Conctc.2017.02.007 |
0.459 |
|
| 2017 |
Kim DJ, Kim K, Lee HW, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Jeon HJ. Internet Game Addiction, Depression, and Escape From Negative Emotions in Adulthood: A Nationwide Community Sample of Korea. The Journal of Nervous and Mental Disease. PMID 28598958 DOI: 10.1097/NMD.0000000000000698 |
0.494 |
|
| 2017 |
Perlman G, Bartlett E, DeLorenzo C, Weissman M, McGrath P, Ogden T, Jin T, Adams P, Trivedi M, Kurian B, Oquendo M, McInnis M, Weyandt S, Fava M, Cooper C, et al. Cortical thickness is not associated with current depression in a clinical treatment study. Human Brain Mapping. PMID 28594150 DOI: 10.1002/Hbm.23664 |
0.501 |
|
| 2017 |
Yeung AS, Feng R, Kim DJH, Wayne PM, Yeh GY, Baer L, Lee OE, Denninger JW, Benson H, Fricchione GL, Alpert J, Fava M. A Pilot, Randomized Controlled Study of Tai Chi With Passive and Active Controls in the Treatment of Depressed Chinese Americans. The Journal of Clinical Psychiatry. 78: e522-e528. PMID 28570792 DOI: 10.4088/Jcp.16M10772 |
0.738 |
|
| 2017 |
Mathew SJ, Gueorguieva R, Brandt C, Fava M, Sanacora G. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28553836 DOI: 10.1038/npp.2017.106 |
0.567 |
|
| 2017 |
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, et al. Guidelines for the recognition and management of mixed depression. Cns Spectrums. 1-17. PMID 28421980 DOI: 10.1017/S1092852917000165 |
0.553 |
|
| 2017 |
Swann AC, Fava M, Tsai J, Mao Y, Pikalov A, Loebel A. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis. Cns Spectrums. 1-8. PMID 28300012 DOI: 10.1017/S1092852917000232 |
0.544 |
|
| 2017 |
de Jong M, Peeters F, Gard T, Ashih H, Doorley J, Walker R, Rhoades L, Kulich RJ, Kueppenbender KD, Alpert JE, Hoge EA, Britton WB, Lazar SW, Fava M, Mischoulon D. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain. The Journal of Clinical Psychiatry. PMID 28252881 DOI: 10.4088/Jcp.15M10160 |
0.646 |
|
| 2017 |
Freeman MP, Fisher L, Clain A, Rabbitt R, Pooley J, Baer L, Fava M. Differentiating residual symptoms of depression from adverse events among patients initiating treatment with an antidepressant. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 29: 28-34. PMID 28207913 |
0.448 |
|
| 2017 |
Fava M, Weiller E, Zhang P, Weiss C. Efficacy of Brexpiprazole as Adjunctive Treatment in Major Depressive Disorder With Irritability: Post Hoc Analysis of 2 Pivotal Clinical Studies. Journal of Clinical Psychopharmacology. PMID 28195853 DOI: 10.1097/JCP.0000000000000678 |
0.562 |
|
| 2017 |
Freeman MP, Pooley J, Flynn MJ, Baer L, Mischoulon D, Mou D, Fava M. Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials. Journal of Clinical Psychopharmacology. PMID 28187008 DOI: 10.1097/JCP.0000000000000669 |
0.576 |
|
| 2017 |
Delaparte L, Yeh FC, Adams P, Malchow A, Trivedi MH, Oquendo MA, Deckersbach T, Ogden T, Pizzagalli DA, Fava M, Cooper C, McInnis M, Kurian BT, Weissman MM, McGrath PJ, et al. A comparison of structural connectivity in anxious depression versus non-anxious depression. Journal of Psychiatric Research. 89: 38-47. PMID 28157545 DOI: 10.1016/J.Jpsychires.2017.01.012 |
0.578 |
|
| 2017 |
Rutrick D, Stein DJ, Subramanian G, Smith B, Fava M, Hasler G, Cha JH, Gasparini F, Donchev T, Ocwieja M, Johns D, Gomez-Mancilla B. Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study. Advances in Therapy. PMID 28044255 DOI: 10.1007/S12325-016-0468-5 |
0.345 |
|
| 2017 |
Cooper C, Fatt CC, Delarosa B, Grannerman B, Fava M, Kurian B, McGrath P, McInnis M, Parsey R, Weissman M, Bruder G, Tenke C, Hart J, Trivedi M. 939. Identifying Clinically Relevant Electroencephalography Coherence Patterns in Major Depressive Disorder: Results from the EMBARC Study Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.665 |
0.541 |
|
| 2017 |
Webb C, Trivedi M, Fava M, McGrath P, Weissman M, Parsey R, Dillon D, Pechtel P, Goer F, Adams P, Trombello J, Cooper C, Deldin P, Tenke C, Carmody T, et al. 173. The Incremental Predictive Validity of Rostral Anterior Cingulate Cortex Activity in Relation to Treatment Response in Depression: Evidence from the EMBARC Study Biological Psychiatry. 81: S72. DOI: 10.1016/J.Biopsych.2017.02.186 |
0.456 |
|
| 2016 |
Jeon HJ, Woo JM, Kim HJ, Fava M, Mischoulon D, Cho SJ, Chang SM, Park DH, Kim JW, Yoo I, Heo JY, Hong JP. Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder. Psychiatry Investigation. 13: 609-615. PMID 27909451 DOI: 10.4306/pi.2016.13.6.609 |
0.545 |
|
| 2016 |
Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Clinical Psychiatry. PMID 27835715 DOI: 10.4088/JCP.15m10426 |
0.485 |
|
| 2016 |
Fava M, Okame T, Matsushima Y, Perry P, Weiller E, Baker RA. Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning. The International Journal of Neuropsychopharmacology. PMID 27784751 DOI: 10.1093/ijnp/pyw087 |
0.578 |
|
| 2016 |
Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. Journal of Affective Disorders. 208: 6-14. PMID 27736689 DOI: 10.1016/J.Jad.2016.08.029 |
0.747 |
|
| 2016 |
Stauffer VL, Liu P, Goldberger C, Marangell LB, Nelson C, Gorwood P, Fava M. Is the Noradrenergic Symptom Cluster a Valid Construct in Adjunctive Treatment of Major Depressive Disorder? The Journal of Clinical Psychiatry. PMID 27685842 DOI: 10.4088/JCP.15m09972 |
0.522 |
|
| 2016 |
Ma Y, Yeung A, Yang AC, Peng CK, Clain A, Alpert J, Fava M, Yeung AS. The Effects of Tai Chi on Sleep Quality in Chinese American Patients With Major Depressive Disorder: A Pilot Study. Behavioral Sleep Medicine. 1-17. PMID 27676270 DOI: 10.1080/15402002.2016.1228643 |
0.686 |
|
| 2016 |
Chen JA, Shapero BG, Trinh NT, Chang TE, Parkin S, Alpert JE, Fava M, Yeung AS. Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care Setting. The Journal of Clinical Psychiatry. PMID 27631145 DOI: 10.4088/Jcp.15M10225 |
0.653 |
|
| 2016 |
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nature Reviews. Disease Primers. 2: 16065. PMID 27629598 DOI: 10.1038/nrdp.2016.65 |
0.419 |
|
| 2016 |
Harper DG, Jensen JE, Ravichandran C, Perlis RH, Fava M, Renshaw PF, Iosifescu DV. Tissue Type Specific Bioenergetic Abnormalities in Adults with Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27585738 DOI: 10.1038/Npp.2016.180 |
0.675 |
|
| 2016 |
Yeung A, Martinson MA, Baer L, Chen J, Clain A, Williams A, Chang TE, Trinh NT, Alpert JE, Fava M. The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: e996-e1002. PMID 27561153 DOI: 10.4088/Jcp.15M09952 |
0.675 |
|
| 2016 |
Harel EV, Tennyson RL, Fava M, Bar M. Linking major depression and the neural substrates of associative processing. Cognitive, Affective & Behavioral Neuroscience. PMID 27553369 DOI: 10.3758/s13415-016-0449-9 |
0.656 |
|
| 2016 |
Chang KJ, Kim K, Fava M, Mischoulon D, Hong JP, Kim DJ, Heo JY, Choi H, Jeon HJ. Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder. Psychiatry Research. 245: 127-132. PMID 27541348 DOI: 10.1016/j.psychres.2016.08.019 |
0.493 |
|
| 2016 |
Fava M, Ménard F, Davidsen CK, Baker RA. Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study. The Journal of Clinical Psychiatry. PMID 27379823 DOI: 10.4088/JCP.15m10470 |
0.58 |
|
| 2016 |
Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ. Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood. Journal of Affective Disorders. 203: 275-280. PMID 27314814 DOI: 10.1016/j.jad.2016.06.007 |
0.566 |
|
| 2016 |
Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, et al. Inflammatory cytokines in major depressive disorder: A case-control study. The Australian and New Zealand Journal of Psychiatry. PMID 27313138 DOI: 10.1177/0004867416652736 |
0.713 |
|
| 2016 |
Ionescu DF, Shelton RC, Baer L, Meade KH, Swee MB, Fava M, Papakostas GI. Ziprasidone augmentation for anxious depression. International Clinical Psychopharmacology. PMID 27306192 DOI: 10.1097/YIC.0000000000000133 |
0.527 |
|
| 2016 |
Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Heo JY, Kim KW, Kim ST, Kim DJ, Kim DK, Seo SW, Seong JK, Jeon HJ. Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder. Translational Psychiatry. 6: e835. PMID 27271861 DOI: 10.1038/Tp.2016.110 |
0.37 |
|
| 2016 |
Papakostas GI, Martinson MA, Fava M, Iovieno N. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression. The Journal of Clinical Psychiatry. 77: e619-24. PMID 27249092 DOI: 10.4088/JCP.14r09767 |
0.596 |
|
| 2016 |
Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ. Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder. Psychiatry Investigation. 13: 321-6. PMID 27247599 DOI: 10.4306/pi.2016.13.3.321 |
0.591 |
|
| 2016 |
Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. The Journal of Clinical Psychiatry. PMID 27232360 DOI: 10.4088/Jcp.15M10056 |
0.644 |
|
| 2016 |
Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. The American Journal of Psychiatry. appiajp201615091228. PMID 27113121 DOI: 10.1176/Appi.Ajp.2016.15091228 |
0.48 |
|
| 2016 |
Otto MW, Lee J, Hofmann SG, Hearon BA, Smits JA, Rosenfield D, Fava M, Wright JH. Examining the Efficacy of D-cycloserine to Augment Therapeutic Learning in Depression. Contemporary Clinical Trials. PMID 27094721 DOI: 10.1016/J.Cct.2016.03.009 |
0.433 |
|
| 2016 |
Isitt JJ, Nadipelli VR, Kouassi A, Fava M, Heidbreder C. Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study. Schizophrenia Research. PMID 27066860 DOI: 10.1016/j.schres.2016.03.020 |
0.303 |
|
| 2016 |
Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, et al. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. The American Journal of Psychiatry. appiajp201616010037. PMID 27056608 DOI: 10.1176/Appi.Ajp.2016.16010037 |
0.533 |
|
| 2016 |
Durgam S, Earley W, Guo H, Li D, Németh G, Laszlovszky I, Fava M, Montgomery SA. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder. The Journal of Clinical Psychiatry. 77: 371-8. PMID 27046309 DOI: 10.4088/JCP.15m10070 |
0.555 |
|
| 2016 |
Trivedi MH, McGrath PJ, Fava M, Parsey RV, Kurian BT, Phillips ML, Oquendo MA, Bruder G, Pizzagalli D, Toups M, Cooper C, Adams P, Weyandt S, Morris DW, Grannemann BD, et al. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. Journal of Psychiatric Research. 78: 11-23. PMID 27038550 DOI: 10.1016/J.Jpsychires.2016.03.001 |
0.543 |
|
| 2016 |
Petryshen TL, Lewis MC, Dennehy KA, Garza JC, Fava M. Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice. Neuroscience Letters. 620: 70-73. PMID 27033002 DOI: 10.1016/j.neulet.2016.03.051 |
0.462 |
|
| 2016 |
Ionescu DF, Fava M, Kim DJ, Baer L, Shelton RC, Cusin C. A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder. Therapeutic Advances in Psychopharmacology. 6: 4-12. PMID 26913173 DOI: 10.1177/2045125315618621 |
0.534 |
|
| 2016 |
Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, ... Fava M, et al. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. The Australian and New Zealand Journal of Psychiatry. PMID 26893373 DOI: 10.1177/0004867416631828 |
0.478 |
|
| 2016 |
Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E. Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial. The American Journal of Psychiatry. appiajp201515070921. PMID 26869247 DOI: 10.1176/appi.ajp.2015.15070921 |
0.397 |
|
| 2016 |
Nasser AF, Henderson DC, Fava M, Fudala PJ, Twumasi-Ankrah P, Kouassi A, Heidbreder C. Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study. Journal of Clinical Psychopharmacology. PMID 26862829 DOI: 10.1097/JCP.0000000000000479 |
0.322 |
|
| 2016 |
Huz I, Nyer M, Dickson C, Farabaugh A, Alpert J, Fava M, Baer L. Obsessive-Compulsive Symptoms as a Risk Factor for Suicidality in U.S. College Students. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 26803200 DOI: 10.1016/J.Jadohealth.2015.11.011 |
0.52 |
|
| 2016 |
Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ. PS281. Lifetime suicidal ideation and attempt in community adults with full major depressive disorder versus only sustained depressed mood The International Journal of Neuropsychopharmacology. 19: 101-102. DOI: 10.1093/Ijnp/Pyw043.281 |
0.546 |
|
| 2016 |
Flynn M, Leonardi T, Pooley J, Iovieno N, Fava M. Use of independent remote (safer) patient interviews in clinical trials for MDD at European study sites European Neuropsychopharmacology. 26: S402-S403. DOI: 10.1016/S0924-977X(16)31364-5 |
0.308 |
|
| 2016 |
Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, Mischoulon D, Worthington J, DeVivo I, Fava M, Wong KK. Corrigendum to "Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls" [Psychoneuroendocrinology 58, (2015), 9-22] Psychoneuroendocrinology. 63: 411. DOI: 10.1016/J.Psyneuen.2015.05.010 |
0.388 |
|
| 2016 |
Baek JH, Heo J, Fava M, Mischoulon D, Nierenberg A, Hong J, Roh S, Jeon HJ. Corrigendum to ''Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder'' [J. Affect. Disord. 187 (2015) 183–187] Journal of Affective Disorders. 193: 185-186. DOI: 10.1016/j.jad.2016.01.001 |
0.514 |
|
| 2015 |
Iovieno N, Nierenberg AA, Parkin SR, Hyung Kim DJ, Walker RS, Fava M, Papakostas GI. Relationship between placebo response rate and clinical trial outcome in bipolar depression. Journal of Psychiatric Research. 74: 38-44. PMID 26736040 DOI: 10.1016/j.jpsychires.2015.12.016 |
0.397 |
|
| 2015 |
Baer L, Trivedi MH, Huz I, Rush AJ, Wisniewski SR, Fava M. Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D report. The Journal of Clinical Psychiatry. 76: 1668-74. PMID 26717526 DOI: 10.4088/Jcp.14M09670 |
0.591 |
|
| 2015 |
Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Lee DW, Heo JY, Jeon HJ. Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults. Journal of Affective Disorders. 191: 222-229. PMID 26682491 DOI: 10.1016/j.jad.2015.11.050 |
0.494 |
|
| 2015 |
Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry. PMID 26643541 DOI: 10.1038/Mp.2015.178 |
0.489 |
|
| 2015 |
Freeman MP, Fava M, Gommoll C, Chen C, Greenberg WM, Ruth A. Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder. International Clinical Psychopharmacology. PMID 26584326 DOI: 10.1097/YIC.0000000000000104 |
0.54 |
|
| 2015 |
Olvet DM, Delaparte L, Yeh FC, DeLorenzo C, McGrath PJ, Weissman MM, Adams P, Fava M, Deckersbach T, McInnis MG, Carmody TJ, Cooper CM, Kurian BT, Lu H, Toups MS, et al. A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER. Depression and Anxiety. PMID 26477532 DOI: 10.1002/da.22445 |
0.463 |
|
| 2015 |
Brennan FX, Gardner KR, Lombard J, Perlis RH, Fava M, Harris HW, Scott R. A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders. The Primary Care Companion For Cns Disorders. 17. PMID 26445691 DOI: 10.4088/Pcc.14M01717 |
0.651 |
|
| 2015 |
Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study. Journal of Psychiatric Research. 70: 98-105. PMID 26424428 DOI: 10.1016/j.jpsychires.2015.08.016 |
0.487 |
|
| 2015 |
Fava M. Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder. Jama Psychiatry. 72: 1073-4. PMID 26421499 DOI: 10.1001/jamapsychiatry.2015.1727 |
0.451 |
|
| 2015 |
Fava M. The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 307-8. PMID 26407784 DOI: 10.1002/wps.20247 |
0.477 |
|
| 2015 |
Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry Journal. 2015: 352979. PMID 26356811 DOI: 10.1155/2015/352979 |
0.402 |
|
| 2015 |
Fisher LB, Fava M, Doros GD, Alpert JE, Henry M, Huz I, Freeman MP. The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study. The Journal of Nervous and Mental Disease. 203: 762-8. PMID 26348584 DOI: 10.1097/Nmd.0000000000000364 |
0.723 |
|
| 2015 |
Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, Roh S, Jeon HJ. Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. Journal of Affective Disorders. 187: 183-7. PMID 26342171 DOI: 10.1016/j.jad.2015.08.006 |
0.495 |
|
| 2015 |
Baek JH, Park JI, Ahn J, Roh SW, Heo JY, Fava M, Mischoulon D, Jeon HJ. Review of Suicide Prevention Programs: Massachusetts, United States, in Comparison with Seoul. Psychiatry Investigation. 12: 281-7. PMID 26207119 DOI: 10.4306/pi.2015.12.3.281 |
0.302 |
|
| 2015 |
Greenberg T, Chase HW, Almeida JR, Stiffler R, Zevallos CR, Aslam HA, Deckersbach T, Weyandt S, Cooper C, Toups M, Carmody T, Kurian B, Peltier S, Adams P, McInnis MG, ... ... Fava M, et al. Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study. The American Journal of Psychiatry. 172: 881-91. PMID 26183698 DOI: 10.1176/Appi.Ajp.2015.14050594 |
0.478 |
|
| 2015 |
Yoo I, Woo JM, Lee SH, Fava M, Mischoulon D, Papakostas GI, Kim EJ, Chung S, Ha JH, Jeon HJ. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. Journal of Affective Disorders. 185: 24-30. PMID 26142691 DOI: 10.1016/j.jad.2015.06.038 |
0.569 |
|
| 2015 |
Goldberg JF, Freeman MP, Balon R, Citrome L, Thase ME, Kane JM, Fava M. THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS. Depression and Anxiety. 32: 605-13. PMID 26129956 DOI: 10.1002/da.22378 |
0.427 |
|
| 2015 |
Papakostas GI, Fava M, Baer L, Swee MB, Jaeger A, Bobo WV, Shelton RC. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study. The American Journal of Psychiatry. appiajp201514101251. PMID 26085041 DOI: 10.1176/appi.ajp.2015.14101251 |
0.574 |
|
| 2015 |
Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders. Journal of Affective Disorders. 184: 81-8. PMID 26074016 DOI: 10.1016/j.jad.2015.05.028 |
0.566 |
|
| 2015 |
Webb CA, Dillon DG, Pechtel P, Goer FK, Murray L, Huys QJ, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian BT, Adams P, Weyandt S, Trombello JM, Grannemann B, et al. Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26068725 DOI: 10.1038/Npp.2015.165 |
0.4 |
|
| 2015 |
Targum SD, Wedel PC, Fava M. Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder. Journal of Psychiatric Research. 68: 392-6. PMID 26025562 DOI: 10.1016/j.jpsychires.2015.04.024 |
0.478 |
|
| 2015 |
Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry. 48: 141-4. PMID 26011569 DOI: 10.1055/S-0035-1549928 |
0.521 |
|
| 2015 |
Farabaugh A, Fisher L, Nyer M, Holt D, Cohen M, Baer L, Shapero BG, Huz I, Cardoos A, Fava M, Alpert JE. Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 118-26. PMID 25954938 |
0.597 |
|
| 2015 |
Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A. College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 100-8. PMID 25954936 |
0.672 |
|
| 2015 |
Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB, Fava M, Mischoulon D. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evidence-Based Complementary and Alternative Medicine : Ecam. 2015: 949036. PMID 25954318 DOI: 10.1155/2015/949036 |
0.326 |
|
| 2015 |
Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, Mischoulon D, Worthington J, DeVivo I, Fava M, Wong KK. Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology. 58: 9-22. PMID 25932992 DOI: 10.1016/J.Psyneuen.2015.04.004 |
0.471 |
|
| 2015 |
Gomeni R, Goyal N, Bressolle F, Fava M. A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25895454 DOI: 10.1038/npp.2015.105 |
0.382 |
|
| 2015 |
Dillon DG, Wiecki T, Pechtel P, Webb C, Goer F, Murray L, Trivedi M, Fava M, McGrath PJ, Weissman M, Parsey R, Kurian B, Adams P, Carmody T, Weyandt S, et al. A computational analysis of flanker interference in depression. Psychological Medicine. 45: 2333-44. PMID 25727375 DOI: 10.1017/S0033291715000276 |
0.516 |
|
| 2015 |
Janes AC, Pedrelli P, Whitton AE, Pechtel P, Douglas S, Martinson MA, Huz I, Fava M, Pizzagalli DA, Evins AE. Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1940-6. PMID 25662839 DOI: 10.1038/Npp.2015.43 |
0.408 |
|
| 2015 |
Heo JY, Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, Pisoni A, Papakostas GI. Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial. Journal of Psychiatric Research. 62: 56-61. PMID 25659187 DOI: 10.1016/j.jpsychires.2015.01.007 |
0.595 |
|
| 2015 |
Chen JA, Hung GC, Parkin S, Fava M, Yeung AS. Illness beliefs of Chinese American immigrants with major depressive disorder in a primary care setting. Asian Journal of Psychiatry. 13: 16-22. PMID 25563074 DOI: 10.1016/j.ajp.2014.12.005 |
0.483 |
|
| 2015 |
Chen JA, Vijapura S, Papakostas GI, Parkin SR, Kim DJ, Cusin C, Baer L, Clain AJ, Fava M, Mischoulon D. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group. Asian Journal of Psychiatry. 13: 23-9. PMID 25544195 DOI: 10.1016/j.ajp.2014.12.002 |
0.501 |
|
| 2015 |
Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M. Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1448-55. PMID 25518754 DOI: 10.1038/Npp.2014.330 |
0.385 |
|
| 2015 |
Nierenberg AA, Østergaard SD, Iovieno N, Walker RS, Fava M, Papakostas GI. Predictors of placebo response in bipolar depression. International Clinical Psychopharmacology. 30: 59-66. PMID 25438027 DOI: 10.1097/YIC.0000000000000058 |
0.399 |
|
| 2015 |
Fava M, Ramey T, Pickering E, Kinrys G, Boyer S, Altstiel L. A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels? Journal of Clinical Psychopharmacology. 35: 51-6. PMID 25422883 DOI: 10.1097/JCP.0000000000000245 |
0.515 |
|
| 2015 |
Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, Erb JL, Churchill SE, Kaimal AJ, Doyle AE, Robinson EB, Smoller JW, Kohane IS, Perlis RH. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry. 20: 727-34. PMID 25155880 DOI: 10.1038/mp.2014.90 |
0.63 |
|
| 2015 |
Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biological Psychiatry. 77: 285-94. PMID 25109665 DOI: 10.1016/J.Biopsych.2014.06.018 |
0.516 |
|
| 2015 |
Admon R, Nickerson LD, Dillon DG, Holmes AJ, Bogdan R, Kumar P, Dougherty DD, Iosifescu DV, Mischoulon D, Fava M, Pizzagalli DA. Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties. Psychological Medicine. 45: 121-31. PMID 25055809 DOI: 10.1017/S0033291714001123 |
0.503 |
|
| 2015 |
Shelton R, Pencina M, Barrentine L, Ruiz J, Papakostas G, Zajecka J, Fava M. Association of obesity and levels of Inflammatory markers on treatment outcome with adjunctive L-methylfolate (Deplin) in major depressive disorder patients who are inadequate responders to selective serotonin reuptake Inhibitors F1000research. 6. DOI: 10.7490/F1000Research.1098063.1 |
0.47 |
|
| 2015 |
Cassano P, Trinh NH, Chang T, Dey Hazra RO, Baer L, Cardoos A, Fava M, Mischoulon D. Major depressive disorder with psychosis-like symptoms in Latinos: treatment with and without antipsychotic augmentation International Journal of Culture and Mental Health. 8: 137-149. DOI: 10.1080/17542863.2014.907327 |
0.549 |
|
| 2015 |
Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders Journal of Affective Disorders. 184: 81-88. DOI: 10.1016/j.jad.2015.05.028 |
0.482 |
|
| 2014 |
Fagerness J, Fonseca E, Hess GP, Scott R, Gardner KR, Koffler M, Fava M, Perlis R, Brennan FX, Lombard J. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. The American Journal of Managed Care. 20: e146-56. PMID 25326929 |
0.546 |
|
| 2014 |
Roffman JL, Witte JM, Tanner AS, Ghaznavi S, Abernethy RS, Crain LD, Giulino PU, Lable I, Levy RA, Dougherty DD, Evans KC, Fava M. Neural predictors of successful brief psychodynamic psychotherapy for persistent depression. Psychotherapy and Psychosomatics. 83: 364-70. PMID 25323387 DOI: 10.1159/000364906 |
0.564 |
|
| 2014 |
Thase ME, Fava M, Nierenberg AA. Depression: addressing partial response after first-line antidepressant treatment. The Journal of Clinical Psychiatry. 75: 978-80. PMID 25295423 DOI: 10.4088/JCP.13018co4c |
0.529 |
|
| 2014 |
Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker RS, Fava M. Reliability and validity of the Symptoms of Depression Questionnaire (SDQ). Cns Spectrums. 19: 535-46. PMID 25275853 DOI: 10.1017/S1092852914000406 |
0.763 |
|
| 2014 |
Yeung A, Slipp LE, Niles H, Jacquart J, Chow CL, Fava M, Denninger JW, Benson H, Fricchione GL. Effectiveness of the relaxation response-based group intervention for treating depressed chinese american immigrants: a pilot study. International Journal of Environmental Research and Public Health. 11: 9186-201. PMID 25198683 DOI: 10.3390/Ijerph110909186 |
0.467 |
|
| 2014 |
Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, Heo JY, Jeon HJ. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. Journal of Affective Disorders. 169: 112-7. PMID 25189990 DOI: 10.1016/j.jad.2014.08.009 |
0.475 |
|
| 2014 |
Calabrese JR, Fava M, Garibaldi G, Grunze H, Krystal AD, Laughren T, Macfadden W, Marin R, Nierenberg AA, Tohen M. Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. Journal of Affective Disorders. 168: 439-51. PMID 25113957 DOI: 10.1016/j.jad.2014.06.056 |
0.372 |
|
| 2014 |
Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, McQuade RD, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial. Psychiatric Services (Washington, D.C.). 65: 1058-61. PMID 25082605 DOI: 10.1176/appi.ps.201300326 |
0.387 |
|
| 2014 |
Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rose S, Sampson NA, Schoevers RA, Wilcox MA, Alonso J, Bromet EJ, et al. The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity. Psychological Medicine. 44: 3289-302. PMID 25066141 DOI: 10.1017/S0033291714000993 |
0.468 |
|
| 2014 |
Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE, Cohen AL, Fava M, Kaplan GB. Associations among smoking, anhedonia, and reward learning in depression. Behavior Therapy. 45: 651-63. PMID 25022776 DOI: 10.1016/J.Beth.2014.02.004 |
0.481 |
|
| 2014 |
Jeon HJ, Park JI, Fava M, Mischoulon D, Sohn JH, Seong S, Park JE, Yoo I, Cho MJ. Feelings of worthlessness, traumatic experience, and their comorbidity in relation to lifetime suicide attempt in community adults with major depressive disorder. Journal of Affective Disorders. 166: 206-12. PMID 25012433 DOI: 10.1016/j.jad.2014.05.010 |
0.532 |
|
| 2014 |
Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Smoller JW, Perlis RH. An electronic health records study of long-term weight gain following antidepressant use. Jama Psychiatry. 71: 889-96. PMID 24898363 DOI: 10.1001/jamapsychiatry.2014.414 |
0.589 |
|
| 2014 |
Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. Journal of Affective Disorders. 164: 76-81. PMID 24856557 DOI: 10.1016/j.jad.2014.03.041 |
0.488 |
|
| 2014 |
Ostergaard SD, Bech P, Trivedi MH, Wisniewski SR, Rush AJ, Fava M. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). Journal of Affective Disorders. 163: 18-24. PMID 24836083 DOI: 10.1016/J.Jad.2014.03.049 |
0.46 |
|
| 2014 |
Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, DiPierro M, Cardoos A, Papakostas GI. Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial. International Clinical Psychopharmacology. 29: 332-8. PMID 24815673 DOI: 10.1097/YIC.0000000000000039 |
0.486 |
|
| 2014 |
Papakostas GI, Shelton RC, Zajecka JM, Bottiglieri T, Roffman J, Cassiello C, Stahl SM, Fava M. Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. The Journal of Clinical Psychiatry. 75: 855-63. PMID 24813065 DOI: 10.4088/Jcp.13M08947 |
0.486 |
|
| 2014 |
Williams A, Larocca R, Chang T, Trinh NH, Fava M, Kvedar J, Yeung A. Web-based depression screening and psychiatric consultation for college students: a feasibility and acceptability study. International Journal of Telemedicine and Applications. 2014: 580786. PMID 24799895 DOI: 10.1155/2014/580786 |
0.355 |
|
| 2014 |
O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH. Rare copy number variation in treatment-resistant major depressive disorder. Biological Psychiatry. 76: 536-41. PMID 24529801 DOI: 10.1016/j.biopsych.2013.10.028 |
0.726 |
|
| 2014 |
Jeon HJ, Woo JM, Lee SH, Kim EJ, Chung S, Ha JH, Fava M, Mischoulon D, Kim JH, Heo JY, Yu BH. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. Journal of Clinical Psychopharmacology. 34: 218-25. PMID 24525660 DOI: 10.1097/JCP.0000000000000072 |
0.396 |
|
| 2014 |
Fava M. Assessing response to treatment and recognizing residual depressive symptoms. The Journal of Clinical Psychiatry. 75: e01. PMID 24502864 DOI: 10.4088/JCP.13018tx2c |
0.384 |
|
| 2014 |
Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. The Journal of Clinical Psychiatry. 75: 370-6. PMID 24500245 DOI: 10.4088/Jcp.13M08591 |
0.517 |
|
| 2014 |
Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 51: 113-8. PMID 24495778 DOI: 10.1016/j.pnpbp.2014.01.018 |
0.46 |
|
| 2014 |
Jeon HJ, Walker RS, Inamori A, Hong JP, Cho MJ, Baer L, Clain A, Fava M, Mischoulon D. Differences in depressive symptoms between Korean and American outpatients with major depressive disorder. International Clinical Psychopharmacology. 29: 150-6. PMID 24323201 DOI: 10.1097/YIC.0000000000000019 |
0.578 |
|
| 2014 |
Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Comprehensive Psychiatry. 55: 1-10. PMID 24268564 DOI: 10.1016/j.comppsych.2013.08.008 |
0.489 |
|
| 2014 |
Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P, Dube S, Thase ME. Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depression and Anxiety. 31: 250-7. PMID 24115209 DOI: 10.1002/da.22199 |
0.48 |
|
| 2014 |
Trinh NH, Hagan PN, Flaherty K, Traeger LN, Inamori A, Brill CD, Hails K, Chang TE, Bedoya CA, Fava M, Yeung A. Evaluating patient acceptability of a culturally focused psychiatric consultation intervention for Latino Americans with depression. Journal of Immigrant and Minority Health / Center For Minority Public Health. 16: 1271-7. PMID 24097287 DOI: 10.1007/s10903-013-9924-3 |
0.492 |
|
| 2014 |
Fava M. How can we make measures of psychotic depression symptoms more clinically useful? Acta Psychiatrica Scandinavica. 129: 161-2. PMID 23869739 DOI: 10.1111/acps.12177 |
0.492 |
|
| 2014 |
Perlis RH, Cusin C, Fava M. Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder. Psychological Medicine. 44: 1361-7. PMID 22417535 DOI: 10.1017/S0033291712000281 |
0.76 |
|
| 2014 |
Fava M, Gommoll C, Chen C, Greenberg WM, Ruth A, D'Souza I, Terner-Rosenthal J. P.2.f.009 The efficacy of levomilnacipran extended-release (ER) in the treatment of patients with depression-associated fatigue symptoms European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70730-8 |
0.455 |
|
| 2014 |
Singh J, Fedgchin M, Daly E, Boer PD, Cooper K, Lim P, Pinter C, Murrough J, Sanacora G, Shelton R, Kurian B, Winokur A, Fava M, Manji H, Drevets W, et al. P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70618-2 |
0.457 |
|
| 2014 |
Fava M, Freeman M, Williams J, Detke M. EPA-1780 – Are different methods to reduce placebo response in cns trials mutually exclusive or have additive effects? European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78903-5 |
0.324 |
|
| 2013 |
Pedrelli P, Borsari B, Palm KM, Dalton E, Fava M. Combined MI + CBT for Depressive Symptoms and Binge Drinking Among Young Adults: Two Case Studies. Journal of Cognitive Psychotherapy. 27: 235-257. PMID 25170188 DOI: 10.1891/0889-8391.27.3.235 |
0.441 |
|
| 2013 |
Pedrelli P, Nyer M, Holt D, Bakow BR, Fava M, Baer L, Cassiello C, Mulligan M, Cusin C, Farabaugh A. Correlates of irritability in college students with depressive symptoms. The Journal of Nervous and Mental Disease. 201: 953-8. PMID 24177482 DOI: 10.1097/Nmd.0000000000000038 |
0.519 |
|
| 2013 |
Toups MS, Myers AK, Wisniewski SR, Kurian B, Morris DW, Rush AJ, Fava M, Trivedi MH. Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. Psychosomatic Medicine. 75: 863-72. PMID 24163386 DOI: 10.1097/Psy.0000000000000000 |
0.416 |
|
| 2013 |
Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D. Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. Journal of Clinical Psychopharmacology. 33: 827-30. PMID 24091858 DOI: 10.1097/Jcp.0B013E31829Cc3Af |
0.753 |
|
| 2013 |
Kim B, Kang ES, Fava M, Mischoulon D, Soskin D, Yu BH, Lee D, Lee DY, Park HD, Jeon HJ. Follicle-stimulating hormone (FSH), current suicidal ideation and attempt in female patients with major depressive disorder. Psychiatry Research. 210: 951-6. PMID 24080256 DOI: 10.1016/j.psychres.2013.08.057 |
0.355 |
|
| 2013 |
Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry. 74: e636-41. PMID 23945458 DOI: 10.4088/Jcp.12M08093 |
0.767 |
|
| 2013 |
Soskin DP, Holt DJ, Sacco GR, Fava M. Incentive salience: novel treatment strategies for major depression. Cns Spectrums. 18: 307-14. PMID 23903027 DOI: 10.1017/S1092852913000345 |
0.394 |
|
| 2013 |
Dording C, Cassiello C, King F, Pencina M, Fava M, Mischoulon D. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. International Clinical Psychopharmacology. 28: 238-44. PMID 23764521 DOI: 10.1097/Yic.0B013E32836220Df |
0.519 |
|
| 2013 |
Yeung A, Slipp LE, Jacquart J, Fava M, Denninger JW, Benson H, Fricchione GL. The treatment of depressed chinese americans using qigong in a health care setting: a pilot study. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 168784. PMID 23690836 DOI: 10.1155/2013/168784 |
0.429 |
|
| 2013 |
Nyer M, Farabaugh A, Fehling K, Soskin D, Holt D, Papakostas GI, Pedrelli P, Fava M, Pisoni A, Vitolo O, Mischoulon D. Relationship between sleep disturbance and depression, anxiety, and functioning in college students. Depression and Anxiety. 30: 873-80. PMID 23681944 DOI: 10.1002/Da.22064 |
0.502 |
|
| 2013 |
Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, ... Fava M, et al. Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. Journal of Psychopharmacology (Oxford, England). 27: 424-34. PMID 23539641 DOI: 10.1177/0269881113480990 |
0.432 |
|
| 2013 |
Matthews JD, Siefert CJ, Blais MA, Park LT, Siefert CJ, Welch CA, Dubois CM, van Nieuwenhuizen AO, Rooney KO, Seabrook RC, Durham LE, Adams HC, Fava M. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. The Journal of Ect. 29: 170-8. PMID 23519225 DOI: 10.1097/YCT.0b013e31828b3523 |
0.534 |
|
| 2013 |
Cassano P, Chang T, Trinh NH, Baer L, Fava M, Mischoulon D. Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. Journal of Affective Disorders. 150: 578-84. PMID 23489398 DOI: 10.1016/j.jad.2013.02.012 |
0.453 |
|
| 2013 |
Cardoos A, Inamori A, Sanacora G, Fava M, Mischoulon D. Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report. Psychosomatics. 54: 488-92. PMID 23473447 DOI: 10.1016/j.psym.2013.02.002 |
0.541 |
|
| 2013 |
Harte CB, Liverant GI, Sloan DM, Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 46: 73-80. PMID 23436273 DOI: 10.1007/S12160-013-9476-8 |
0.498 |
|
| 2013 |
Jeon HJ, Peng D, Chua HC, Srisurapanont M, Fava M, Bae JN, Man Chang S, Hong JP. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder. Journal of Affective Disorders. 148: 368-74. PMID 23414572 DOI: 10.1016/j.jad.2013.01.001 |
0.5 |
|
| 2013 |
Kornstein SG, Toups M, Rush AJ, Wisniewski SR, Thase ME, Luther J, Warden D, Fava M, Trivedi MH. Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Journal of Women's Health (2002). 22: 121-31. PMID 23398127 DOI: 10.1089/Jwh.2012.3479 |
0.375 |
|
| 2013 |
Nyer M, Holt DJ, Pedrelli P, Fava M, Ameral V, Cassiello CF, Nock MK, Ross M, Hutchinson D, Farabaugh A. Factors that distinguish college students with depressive symptoms with and without suicidal thoughts. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 25: 41-9. PMID 23376869 |
0.349 |
|
| 2013 |
Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. QT interval and antidepressant use: a cross sectional study of electronic health records. Bmj (Clinical Research Ed.). 346: f288. PMID 23360890 DOI: 10.1136/bmj.f288 |
0.614 |
|
| 2013 |
Vitali M, Tedeschini E, Mistretta M, Fehling K, Aceti F, Ceccanti M, Fava M. Adjunctive pregabalin in partial responders with major depressive disorder and residual anxiety. Journal of Clinical Psychopharmacology. 33: 95-8. PMID 23277244 DOI: 10.1097/JCP.0b013e31827b9351 |
0.498 |
|
| 2013 |
Sanchez-Villegas A, Field AE, O'Reilly EJ, Fava M, Gortmaker S, Kawachi I, Ascherio A. Perceived and actual obesity in childhood and adolescence and risk of adult depression. Journal of Epidemiology and Community Health. 67: 81-6. PMID 22766776 DOI: 10.1136/Jech-2012-201435 |
0.389 |
|
| 2013 |
Gilman SE, Trinh NH, Smoller JW, Fava M, Murphy JM, Breslau J. Psychosocial stressors and the prognosis of major depression: a test of Axis IV. Psychological Medicine. 43: 303-16. PMID 22640506 DOI: 10.1017/S0033291712001080 |
0.55 |
|
| 2013 |
Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, ... ... Fava M, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry. 18: 497-511. PMID 22472876 DOI: 10.1038/Mp.2012.21 |
0.659 |
|
| 2013 |
Uher R, Tansey KE, Rietschel M, Henigsberg N, Maier W, Mors O, Hauser J, Placentino A, Souery D, Farmer A, Aitchison KJ, Craig I, McGuffin P, Lewis CM, Ising M, ... ... Fava M, et al. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies American Journal of Psychiatry. 170: 207-217. DOI: 10.1176/Appi.Ajp.2012.12020237 |
0.742 |
|
| 2013 |
Youn SJ, Trinh NH, Shyu I, Chang T, Fava M, Kvedar J, Yeung A. Using online social media, Facebook, in screening for major depressive disorder among college students International Journal of Clinical and Health Psychology. 13: 74-80. DOI: 10.1016/S1697-2600(13)70010-3 |
0.342 |
|
| 2012 |
Trinh NH, Larocca R, Regan S, Chang TE, Gilman SE, Fava M, Yeung A. Using the Electronic Medical Record to Examine Racial and Ethnic Differences in Depression Diagnosis and Treatment in a Primary Care Population. Primary Health Care : Open Access. 1: 1000106. PMID 24524015 DOI: 10.4172/2167-1079.1000106 |
0.483 |
|
| 2012 |
Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, ... ... Fava M, et al. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. The Journal of Clinical Psychiatry. 73: 1541-7. PMID 23290327 DOI: 10.4088/Jcp.12M07670 |
0.56 |
|
| 2012 |
Krystal AD, McCall WV, Fava M, Joffe H, Soares CN, Huang H, Grinell T, Zummo J, Spalding W, Marshall R. Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. The Primary Care Companion For Cns Disorders. 14. PMID 23251857 DOI: 10.4088/PCC.11m01296 |
0.383 |
|
| 2012 |
Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, ... ... Fava M, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. The American Journal of Psychiatry. 169: 1267-74. PMID 23212058 DOI: 10.1176/Appi.Ajp.2012.11071114 |
0.639 |
|
| 2012 |
Witte J, Bentley K, Evins AE, Clain AJ, Baer L, Pedrelli P, Fava M, Mischoulon D. A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder. Journal of Clinical Psychopharmacology. 32: 787-96. PMID 23131884 DOI: 10.1097/Jcp.0B013E3182726764 |
0.47 |
|
| 2012 |
Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Epidemiologic evidence concerning the bereavement exclusion in major depression. Archives of General Psychiatry. 69: 1179-80; author repl. PMID 23117639 DOI: 10.1001/archgenpsychiatry.2012.383 |
0.552 |
|
| 2012 |
Perlis RH, Uher R, Perroud N, Fava M. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of Clinical Psychiatry. 73: 1439-42. PMID 23059018 DOI: 10.4088/JCP.12m07777 |
0.707 |
|
| 2012 |
Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. The American Journal of Psychiatry. 169: 1065-72. PMID 23032386 DOI: 10.1176/appi.ajp.2012.11091325 |
0.719 |
|
| 2012 |
Fava M, Targum SD, Nierenberg AA, Bleicher LS, Carter TA, Wedel PC, Hen R, Gage FH, Barlow C. An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. Journal of Psychiatric Research. 46: 1553-63. PMID 22998742 DOI: 10.1016/J.Jpsychires.2012.08.013 |
0.521 |
|
| 2012 |
Nierenberg AA, Bentley KH, Farabaugh AH, Fava M, Deckersbach T. The absence of depressive symptoms is not the presence of wellness: validation of the Clinical Positive Affect Scale. The Australian and New Zealand Journal of Psychiatry. 46: 1165-72. PMID 22990434 DOI: 10.1177/0004867412459810 |
0.428 |
|
| 2012 |
Farabaugh A, Alpert J, Wisniewski SR, Otto MW, Fava M, Baer L, Perlis R, Friedman E, Nyer M, Bitran S, Balasubramani GK, Inamori A, Trivedi M, Thase ME. Cognitive therapy for anxious depression in STAR(*) D: what have we learned? Journal of Affective Disorders. 142: 213-8. PMID 22877961 DOI: 10.1016/J.Jad.2012.04.029 |
0.825 |
|
| 2012 |
Cusin C, Hilton GQ, Nierenberg AA, Fava M. Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression. The American Journal of Psychiatry. 169: 868-9. PMID 22854933 DOI: 10.1176/appi.ajp.2012.12020219 |
0.47 |
|
| 2012 |
Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics. 81: 312-4. PMID 22854752 DOI: 10.1159/000337053 |
0.499 |
|
| 2012 |
Yeung A, Feldman G, Pedrelli P, Hails K, Fava M, Reyes T, Mundt JC. The Quick Inventory of Depressive Symptomatology, clinician rated and self-report: a psychometric assessment in Chinese Americans with major depressive disorder. The Journal of Nervous and Mental Disease. 200: 712-5. PMID 22850307 DOI: 10.1097/Nmd.0B013E318261413D |
0.468 |
|
| 2012 |
Yeung AS, Jing Y, Brenneman SK, Chang TE, Baer L, Hebden T, Kalsekar I, McQuade RD, Kurlander J, Siebenaler J, Fava M. Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depression and Anxiety. 29: 865-73. PMID 22807244 DOI: 10.1002/da.21983 |
0.483 |
|
| 2012 |
Yeung A, Lepoutre V, Wayne P, Yeh G, Slipp LE, Fava M, Denninger JW, Benson H, Fricchione GL. Tai chi treatment for depression in Chinese Americans: a pilot study. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 91: 863-70. PMID 22790795 DOI: 10.1097/Phm.0B013E31825F1A67 |
0.537 |
|
| 2012 |
Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. Cns Spectrums. 17: 76-86. PMID 22789065 DOI: 10.1017/S1092852912000430 |
0.575 |
|
| 2012 |
Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. The Journal of Clinical Psychiatry. 73: 843-8. PMID 22687580 DOI: 10.4088/Jcp.11M07139 |
0.646 |
|
| 2012 |
Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of Clinical Psychiatry. 73: 967-76. PMID 22687487 DOI: 10.4088/Jcp.11M07043 |
0.496 |
|
| 2012 |
Soskin DP, Carl JR, Alpert J, Fava M. Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder. Cns Neuroscience & Therapeutics. 18: 441-51. PMID 22672296 DOI: 10.1111/J.1755-5949.2012.00318.X |
0.677 |
|
| 2012 |
Farabaugh A, Bitran S, Nyer M, Holt DJ, Pedrelli P, Shyu I, Hollon SD, Zisook S, Baer L, Busse W, Petersen TJ, Pender M, Tucker DD, Fava M. Depression and suicidal ideation in college students. Psychopathology. 45: 228-34. PMID 22627683 DOI: 10.1159/000331598 |
0.437 |
|
| 2012 |
Sarris J, Fava M, Schweitzer I, Mischoulon D. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Pharmacopsychiatry. 45: 275-8. PMID 22592504 DOI: 10.1055/s-0032-1306348 |
0.516 |
|
| 2012 |
Hails K, Brill CD, Chang T, Yeung A, Fava M, Trinh NH. Cross-cultural aspects of depression management in primary care. Current Psychiatry Reports. 14: 336-44. PMID 22580834 DOI: 10.1007/s11920-012-0276-9 |
0.393 |
|
| 2012 |
Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. Journal of Affective Disorders. 141: 469-73. PMID 22521855 DOI: 10.1016/j.jad.2012.03.023 |
0.469 |
|
| 2012 |
Davis LL, Pilkinton P, Wisniewski SR, Trivedi MH, Gaynes BN, Howland RH, Zisook S, Balasubramani GK, Fava M, Rush AJ. Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depression and Anxiety. 29: 111-22. PMID 22495941 DOI: 10.1002/Da.20918 |
0.568 |
|
| 2012 |
Castro VM, Gallagher PJ, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. Bmj Open. 2: e000544. PMID 22466034 DOI: 10.1136/bmjopen-2011-000544 |
0.648 |
|
| 2012 |
Cassano P, Fava M, Mischoulon D. Major depressive disorder with psychosis-like symptoms among Latinos. Psychiatric Services (Washington, D.C.). 63: 482-7. PMID 22422016 DOI: 10.1176/appi.ps.201100271 |
0.514 |
|
| 2012 |
Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychotherapy and Psychosomatics. 81: 87-97. PMID 22286203 DOI: 10.1159/000332050 |
0.41 |
|
| 2012 |
Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar I, Hebden T, McQuade R, Baer L, Kurlander JL, Watkins AK, Siebenaler JA, Fava M. Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34: 105-12. PMID 22264654 DOI: 10.1016/j.genhosppsych.2011.12.003 |
0.517 |
|
| 2012 |
Targum SD, Hassman H, Pinho M, Fava M. Development of a clinical global impression scale for fatigue. Journal of Psychiatric Research. 46: 370-4. PMID 22236834 DOI: 10.1016/j.jpsychires.2011.12.001 |
0.363 |
|
| 2012 |
Gollan JK, Fava M, Kurian B, Wisniewski SR, Rush AJ, Daly E, Miyahara S, Trivedi MH. What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? Depression and Anxiety. 29: 94-101. PMID 22147631 DOI: 10.1002/Da.20917 |
0.521 |
|
| 2012 |
Chan HN, Rush AJ, Nierenberg AA, Trivedi M, Wisniewski SR, Balasubramani GK, Friedman ES, Gaynes BN, Davis L, Morris D, Fava M. Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1387-99. PMID 22129562 DOI: 10.1017/S1461145711001660 |
0.522 |
|
| 2012 |
Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatrica Scandinavica. 125: 342-8. PMID 22077211 DOI: 10.1111/j.1600-0447.2011.01791.x |
0.439 |
|
| 2012 |
Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychological Medicine. 42: 1131-49. PMID 22008447 DOI: 10.1017/S0033291711002170 |
0.428 |
|
| 2012 |
Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. The Journal of Clinical Psychiatry. 73: 353-7. PMID 21939613 DOI: 10.4088/Jcp.10M06541 |
0.412 |
|
| 2012 |
Tran P, Skolnick P, Czobor P, Huang NY, Bradshaw M, McKinney A, Fava M. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research. 46: 64-71. PMID 21925682 DOI: 10.1016/J.Jpsychires.2011.09.003 |
0.553 |
|
| 2012 |
Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 183-99. PMID 21920711 DOI: 10.1016/J.Euroneuro.2011.07.010 |
0.509 |
|
| 2012 |
Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Bereavement and the diagnosis of major depressive episode in the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry. 73: 208-15. PMID 21903020 DOI: 10.4088/JCP.10m06080 |
0.569 |
|
| 2012 |
Perlis RH, Iosifescu DV, Castro VM, Murphy SN, Gainer VS, Minnier J, Cai T, Goryachev S, Zeng Q, Gallagher PJ, Fava M, Weilburg JB, Churchill SE, Kohane IS, Smoller JW. Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychological Medicine. 42: 41-50. PMID 21682950 DOI: 10.1017/S0033291711000997 |
0.679 |
|
| 2012 |
Soskin DP, Cassiello C, Isacoff O, Fava M. The Inflammatory Hypothesis of Depression Focus. 10: 413-421. DOI: 10.1176/APPI.FOCUS.10.4.413 |
0.407 |
|
| 2012 |
Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study):(Psychotherapy and Psychosomatics (2012) 81, (87-97)) Psychotherapy and Psychosomatics. 81: 261. DOI: 10.1159/000337702 |
0.376 |
|
| 2011 |
Yeung A, Trinh NH, Chang TE, Fava M. The Engagement Interview Protocol (EIP): improving the acceptance of mental health treatment among Chinese immigrants. International Journal of Culture and Mental Health. 4: 91-105. PMID 25076983 DOI: 10.1080/17542863.2010.507933 |
0.485 |
|
| 2011 |
Targum SD, Fava M. Fatigue as a residual symptom of depression. Innovations in Clinical Neuroscience. 8: 40-3. PMID 22132370 |
0.379 |
|
| 2011 |
Zisook S, Lesser IM, Lebowitz B, Rush AJ, Kallenberg G, Wisniewski SR, Nierenberg AA, Fava M, Luther JF, Morris DW, Trivedi MH. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of Clinical Psychiatry. 72: 1322-32. PMID 22075098 DOI: 10.4088/Jcp.10M06724 |
0.481 |
|
| 2011 |
McClintock SM, Husain MM, Bernstein IH, Wisniewski SR, Trivedi MH, Morris D, Alpert J, Warden D, Luther JF, Kornstein SG, Biggs MM, Fava M, Rush AJ. Assessing anxious features in depressed outpatients. International Journal of Methods in Psychiatric Research. 20: e69-82. PMID 22057975 DOI: 10.1002/Mpr.353 |
0.7 |
|
| 2011 |
Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. The Journal of Clinical Psychiatry. 72: 1669-76. PMID 22053942 DOI: 10.4088/JCP.10m06453 |
0.522 |
|
| 2011 |
Trinh NH, Bedoya CA, Chang TE, Flaherty K, Fava M, Yeung A. A study of a culturally focused psychiatric consultation service for Asian American and Latino American primary care patients with depression. Bmc Psychiatry. 11: 166. PMID 21995514 DOI: 10.1186/1471-244X-11-166 |
0.45 |
|
| 2011 |
Lesser IM, Zisook S, Gaynes BN, Wisniewski SR, Luther JF, Fava M, Khan A, McGrath P, Warden D, Rush AJ, Trivedi M. Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatric Services (Washington, D.C.). 62: 1167-79. PMID 21969643 DOI: 10.1176/Ps.62.10.Pss6210_1167 |
0.552 |
|
| 2011 |
Denninger JW, van Nieuwenhuizen AO, Wisniewski SR, Luther JF, Trivedi MH, Rush AJ, Gollan JK, Pizzagalli DA, Fava M. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. The Journal of Nervous and Mental Disease. 199: 807-10. PMID 21964277 DOI: 10.1097/Nmd.0B013E31822Fcbe2 |
0.475 |
|
| 2011 |
Yeung A, Hails K, Chang T, Trinh NH, Fava M. A study of the effectiveness of telepsychiatry-based culturally sensitive collaborative treatment of depressed Chinese Americans. Bmc Psychiatry. 11: 154. PMID 21943315 DOI: 10.1186/1471-244X-11-154 |
0.453 |
|
| 2011 |
Desseilles M, Witte J, Chang TE, Iovieno N, Dording CM, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. The Journal of Clinical Psychiatry. 72: 1152-4. PMID 21899818 DOI: 10.4088/Jcp.11Ac07225 |
0.41 |
|
| 2011 |
Fava M, Shelton RC, Zajecka JM. Evidence for the use of l-methylfolate combined with antidepressants in MDD. The Journal of Clinical Psychiatry. 72: e25. PMID 21899813 DOI: 10.4088/JCP.11012tx1c |
0.429 |
|
| 2011 |
Farabaugh AH, Locascio JJ, Yap L, Fava M, Bitran S, Sousa JL, Growdon JH. Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 23: 171-7. PMID 21808748 |
0.426 |
|
| 2011 |
Trivedi MH, Wisniewski SR, Morris DW, Fava M, Kurian BT, Gollan JK, Nierenberg AA, Warden D, Gaynes BN, Luther JF, Rush AJ. Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. The Journal of Clinical Psychiatry. 72: 765-74. PMID 21733477 DOI: 10.4088/Jcp.11M06840 |
0.329 |
|
| 2011 |
Fava M, Dording CM, Baker RA, Mankoski R, Tran QV, Forbes RA, Eudicone JM, Owen R, Berman RM. Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies. The Primary Care Companion For Cns Disorders. 13. PMID 21731833 DOI: 10.4088/PCC.10m00994gre |
0.578 |
|
| 2011 |
Sung SC, Dryman MT, Marks E, Shear MK, Ghesquiere A, Fava M, Simon NM. Complicated grief among individuals with major depression: prevalence, comorbidity, and associated features. Journal of Affective Disorders. 134: 453-8. PMID 21621849 DOI: 10.1016/J.Jad.2011.05.017 |
0.48 |
|
| 2011 |
Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of Affective Disorders. 133: 467-76. PMID 21601287 DOI: 10.1016/J.Jad.2011.04.032 |
0.572 |
|
| 2011 |
Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American Journal of Psychiatry. 168: 689-701. PMID 21536692 DOI: 10.1176/Appi.Ajp.2011.10111645 |
0.397 |
|
| 2011 |
Trinh NH, Youn SJ, Sousa J, Regan S, Bedoya CA, Chang TE, Fava M, Yeung A. Using electronic medical records to determine the diagnosis of clinical depression. International Journal of Medical Informatics. 80: 533-40. PMID 21514880 DOI: 10.1016/j.ijmedinf.2011.03.014 |
0.459 |
|
| 2011 |
Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. Journal of Affective Disorders. 132: 396-400. PMID 21440308 DOI: 10.1016/j.jad.2011.03.011 |
0.322 |
|
| 2011 |
Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM. Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. The American Journal of Psychiatry. 168: 593-602. PMID 21406462 DOI: 10.1176/Appi.Ajp.2010.10010032 |
0.635 |
|
| 2011 |
Trinh NH, Shyu I, McGrath PJ, Clain A, Baer L, Fava M, Yeung A. Examining the role of race and ethnicity in relapse rates of major depressive disorder. Comprehensive Psychiatry. 52: 151-5. PMID 21295221 DOI: 10.1016/j.comppsych.2010.05.004 |
0.464 |
|
| 2011 |
Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. International Clinical Psychopharmacology. 26: 206-12. PMID 21278577 DOI: 10.1097/Yic.0B013E328343Ba08 |
0.554 |
|
| 2011 |
Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. The Journal of Clinical Psychiatry. 72: 914-28. PMID 21208597 DOI: 10.4088/JCP.09m05571gry |
0.535 |
|
| 2011 |
Tedeschini E, Fava M, Papakostas GI. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach. The Journal of Clinical Psychiatry. 72: 98-113. PMID 21208576 DOI: 10.4088/JCP.09m05725blu |
0.418 |
|
| 2011 |
Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. The Journal of Clinical Psychiatry. 72: 473-9. PMID 21208574 DOI: 10.4088/JCP.09m05131gry |
0.571 |
|
| 2011 |
Daly EJ, Trivedi MH, Fava M, Shelton R, Wisniewski SR, Morris DW, Stegman D, Preskorn SH, Rush AJ. The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study. Journal of Clinical Psychopharmacology. 31: 31-8. PMID 21192140 DOI: 10.1097/Jcp.0B013E318205E17B |
0.544 |
|
| 2011 |
Perlis RH, Uher R, Ostacher M, Goldberg JF, Trivedi MH, Rush AJ, Fava M. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Archives of General Psychiatry. 68: 351-60. PMID 21135313 DOI: 10.1001/Archgenpsychiatry.2010.179 |
0.726 |
|
| 2011 |
Pedrelli P, Farabaugh AH, Zisook S, Tucker D, Rooney K, Katz J, Clain AJ, Petersen TJ, Fava M. Gender, depressive symptoms and patterns of alcohol use among college students. Psychopathology. 44: 27-33. PMID 20980785 DOI: 10.1159/000315358 |
0.365 |
|
| 2011 |
Fava M, Targum SD. Augmentation and combination strategies to treat the residual symptoms of major depressive disorder. Psychiatry (Edgmont (Pa. : Township)). 4: 16-8. PMID 20805895 |
0.457 |
|
| 2011 |
Yeung AS, Ameral VE, Chuzi SE, Fava M, Mischoulon D. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. Journal of Affective Disorders. 130: 285-9. PMID 20692042 DOI: 10.1016/j.jad.2010.07.025 |
0.581 |
|
| 2011 |
DeBattista C, Kinrys G, Hoffman D, Goldstein C, Zajecka J, Kocsis J, Teicher M, Potkin S, Preda A, Multani G, Brandt L, Schiller M, Iosifescu D, Fava M. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. Journal of Psychiatric Research. 45: 64-75. PMID 20598710 DOI: 10.1016/J.Jpsychires.2010.05.009 |
0.534 |
|
| 2011 |
Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders. 130: 343-57. PMID 20579741 DOI: 10.1016/j.jad.2010.06.010 |
0.564 |
|
| 2011 |
Guidi J, Fava GA, Fava M, Papakostas GI. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychological Medicine. 41: 321-31. PMID 20444307 DOI: 10.1017/S0033291710000826 |
0.55 |
|
| 2011 |
Trivedi MH, Fava M, Marangell LB, Osser DN, Shelton RC. Use of treatment algorithms for depression. Primary Care Companion to the Journal of Clinical Psychiatry. 8: 291-8. PMID 17235386 DOI: 10.4088/PCC.V08N0506 |
0.477 |
|
| 2011 |
Merlo-Pich E, Alexander RC, Fava M, Gomeni R. Response to clinical trials of antidepressants: Enrichment strategies' and the placebo response is part of good medicine Clinical Pharmacology and Therapeutics. 89: 486-487. DOI: 10.1038/clpt.2010.339 |
0.318 |
|
| 2011 |
Tran P, Bradshaw M, McKinney A, Bymaster F, Skolnick P, Czobor P, Huang N, Manthis J, Fava M. P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorder European Neuropsychopharmacology. 21: S384-S385. DOI: 10.1016/S0924-977X(11)70617-4 |
0.512 |
|
| 2011 |
Papakostas G, Shelton R, Zajecka J, Rickels K, Clain A, Baer L, Schoenfeld D, Nelson E, Barbee J, Lydiard B, Mischoulon D, Alpert J, Zisook S, Fava M. L-methylfolate augmentation of selective serotonin reuptake inhibitors (SSRIS) for major depressive disorder: Results of two randomized, double-blind trials European Psychiatry. 26: 592-592. DOI: 10.1016/S0924-9338(11)72299-4 |
0.58 |
|
| 2010 |
Murphy JM, Gilman SE, Lesage A, Horton NJ, Rasic D, Trinh NH, Alamiri B, Sobol AM, Fava M, Smoller JW. Time trends in mortality associated with depression: findings from the Stirling County study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 776-83. PMID 21172098 DOI: 10.1177/070674371005501205 |
0.428 |
|
| 2010 |
Blood AJ, Iosifescu DV, Makris N, Perlis RH, Kennedy DN, Dougherty DD, Kim BW, Lee MJ, Wu S, Lee S, Calhoun J, Hodge SM, Fava M, Rosen BR, Smoller JW, et al. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. Plos One. 5: e13945. PMID 21124764 DOI: 10.1371/Journal.Pone.0013945 |
0.7 |
|
| 2010 |
Fava M, Mischoulon D. Evidence for folate in combination with antidepressants at initiation of therapy. The Journal of Clinical Psychiatry. 71: e31. PMID 21114944 DOI: 10.4088/JCP.8157tx4c |
0.545 |
|
| 2010 |
Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF, Hamilton SP, McMahon FJ, Schulze TG, Schulze T, Potash JB, Zandi PP, Willour VL, Penninx BW, Boomsma DI, et al. Genome-wide association study of suicide attempts in mood disorder patients. The American Journal of Psychiatry. 167: 1499-507. PMID 21041247 DOI: 10.1176/Appi.Ajp.2010.10040541 |
0.79 |
|
| 2010 |
Yeung A, Shyu I, Fisher L, Wu S, Yang H, Fava M. Culturally sensitive collaborative treatment for depressed chinese americans in primary care. American Journal of Public Health. 100: 2397-402. PMID 20966373 DOI: 10.2105/AJPH.2009.184911 |
0.499 |
|
| 2010 |
Fava M. Using complementary and alternative medicines for depression. The Journal of Clinical Psychiatry. 71: e24. PMID 20923617 DOI: 10.4088/JCP.8157tx3c |
0.401 |
|
| 2010 |
Merlo-Pich E, Alexander RC, Fava M, Gomeni R. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clinical Pharmacology and Therapeutics. 88: 634-42. PMID 20861834 DOI: 10.1038/clpt.2010.159 |
0.389 |
|
| 2010 |
Chang T, Fava M. The future of psychopharmacology of depression. The Journal of Clinical Psychiatry. 71: 971-5. PMID 20797377 DOI: 10.4088/JCP.10m06223blu |
0.538 |
|
| 2010 |
Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. The American Journal of Psychiatry. 167: 1254-63. PMID 20713499 DOI: 10.1176/Appi.Ajp.2010.09091335 |
0.75 |
|
| 2010 |
Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI. Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome. Cns Spectrums. 15: 515-21. PMID 20703198 DOI: 10.1017/S1092852900000468 |
0.572 |
|
| 2010 |
Farabaugh A, Sonawalla S, Johnson DP, Witte J, Papakostas GI, Goodness T, Clain A, Baer L, Mischoulon D, Fava M, Harley R. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 22: 166-71. PMID 20680189 |
0.483 |
|
| 2010 |
Sunderajan P, Gaynes BN, Wisniewski SR, Miyahara S, Fava M, Akingbala F, DeVeaugh-Geiss J, Rush AJ, Trivedi MH. Insomnia in patients with depression: a STAR*D report. Cns Spectrums. 15: 394-404. PMID 20625372 DOI: 10.1017/S1092852900029266 |
0.544 |
|
| 2010 |
Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. The American Journal of Psychiatry. 167: 942-8. PMID 20595412 DOI: 10.1176/Appi.Ajp.2009.09081198 |
0.763 |
|
| 2010 |
Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. The Journal of Clinical Psychiatry. 71: 682-8. PMID 20573327 DOI: 10.4088/JCP.10r05976blu |
0.561 |
|
| 2010 |
Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. The Journal of Clinical Psychiatry. 71: 669-81. PMID 20573326 DOI: 10.4088/JCP.10cs05959blu |
0.55 |
|
| 2010 |
Fornaro M, Iovieno N, Clementi N, Boscaro M, Paggi F, Balercia G, Fava M, Papakostas GI. Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 991-6. PMID 20569197 DOI: 10.3109/15622975.2010.491126 |
0.408 |
|
| 2010 |
Kim BW, Kennedy DN, Lehár J, Lee MJ, Blood AJ, Lee S, Perlis RH, Smoller JW, Morris R, Fava M, Breiter HC. Recurrent, robust and scalable patterns underlie human approach and avoidance. Plos One. 5: e10613. PMID 20532247 DOI: 10.1371/Journal.Pone.0010613 |
0.567 |
|
| 2010 |
Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. Journal of Clinical Psychopharmacology. 30: 259-66. PMID 20473060 DOI: 10.1097/Jcp.0B013E3181Dbfd04 |
0.401 |
|
| 2010 |
Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, Baer L, Fava M, McGrath PJ, Dording C, Mischoulon D, Papakostas GI. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. International Clinical Psychopharmacology. 25: 214-7. PMID 20400905 DOI: 10.1097/Yic.0B013E328339Fbbd |
0.767 |
|
| 2010 |
Pedrelli P, Baer L, Losifescu DV, Fava M. Relationship between residual symptoms of depression and self-reported cognitive impairment. Cns Spectrums. 15: 46-51. PMID 20394184 DOI: 10.1017/S1092852900000298 |
0.412 |
|
| 2010 |
Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Archives of General Psychiatry. 67: 369-79. PMID 20368512 DOI: 10.1001/Archgenpsychiatry.2010.18 |
0.496 |
|
| 2010 |
Stahl SM, Fava M, Trivedi MH, Caputo A, Shah A, Post A. Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. The Journal of Clinical Psychiatry. 71: 616-26. PMID 20361916 DOI: 10.4088/JCP.09m05471blu |
0.441 |
|
| 2010 |
Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, Rietschel M, Nöthen MM, Witt S, Maier W, Iosifescu DV, Sullivan P, Rush AJ, Fava M, Breiter H, et al. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. The American Journal of Psychiatry. 167: 574-9. PMID 20360314 DOI: 10.1176/Appi.Ajp.2009.09070973 |
0.742 |
|
| 2010 |
Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-9. PMID 20332287 DOI: 10.1176/appi.psy.51.2.124 |
0.676 |
|
| 2010 |
Tedeschini E, Fava M, Goodness TM, Papakostas GI. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 562-7. PMID 20219330 DOI: 10.1016/j.euroneuro.2010.02.004 |
0.358 |
|
| 2010 |
Papakostas GI, Charles D, Fava M. Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 300-7. PMID 20218793 DOI: 10.3109/15622970701432528 |
0.409 |
|
| 2010 |
Perlis RH, Ostacher M, Fava M, Nierenberg AA, Sachs GS, Rosenbaum JF. Assuring that double-blind is blind. The American Journal of Psychiatry. 167: 250-2. PMID 20194487 DOI: 10.1176/appi.ajp.2009.09060820 |
0.577 |
|
| 2010 |
Fava M. Switching treatments for complicated depression. The Journal of Clinical Psychiatry. 71: e04. PMID 20193643 DOI: 10.4088/JCP.8001tx14c |
0.508 |
|
| 2010 |
Yang H, Sinicropi-Yao L, Chuzi S, Youn SJ, Clain A, Baer L, Chen Y, McGrath PJ, Fava M, Papakostas GI. Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. Annals of General Psychiatry. 9: 10. PMID 20187924 DOI: 10.1186/1744-859X-9-10 |
0.478 |
|
| 2010 |
Bryan C, Songer T, Brooks MM, Rush AJ, Thase ME, Gaynes B, Balasubramani GK, Trivedi MH, Fava M, Wisniewski SR. The impact of diabetes on depression treatment outcomes. General Hospital Psychiatry. 32: 33-41. PMID 20114126 DOI: 10.1016/J.Genhosppsych.2009.07.009 |
0.552 |
|
| 2010 |
Morris DW, Trivedi MH, Husain MM, Fava M, Budhwar N, Wisniewski SR, Miyahara S, Gollan JK, Davis LL, Daly EJ, Rush AJ. Indicators of pretreatment suicidal ideation in adults with major depressive disorder. Acta Psychiatrica Scandinavica. 121: 480-4. PMID 19958307 DOI: 10.1111/J.1600-0447.2009.01516.X |
0.506 |
|
| 2010 |
Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, McGrath PJ, Balasubramani GK, Warden D, Rush AJ. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug and Alcohol Dependence. 107: 161-70. PMID 19945804 DOI: 10.1016/J.Drugalcdep.2009.10.003 |
0.524 |
|
| 2010 |
Papakostas GI, Clain A, Ameral VE, Baer L, Brintz C, Smith WT, Londborg PD, Glaudin V, Painter JR, Fava M. Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Clinical Psychopharmacology. 25: 17-21. PMID 19898245 DOI: 10.1097/YIC.0b013e32833205a4 |
0.603 |
|
| 2010 |
Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). Cns Neuroscience & Therapeutics. 16: 322-5. PMID 19769599 DOI: 10.1111/J.1755-5949.2009.00102.X |
0.433 |
|
| 2010 |
Papakostas GI, Chuzi SE, Sousa JL, Fava M. 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. European Archives of Psychiatry and Clinical Neuroscience. 260: 175-80. PMID 19641981 DOI: 10.1007/s00406-009-0035-z |
0.47 |
|
| 2010 |
Yang H, Chuzi S, Sinicropi-Yao L, Johnson D, Chen Y, Clain A, Baer L, McGrath PJ, Stewart JW, Fava M, Papakostas GI. Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. European Archives of Psychiatry and Clinical Neuroscience. 260: 145-50. PMID 19572158 DOI: 10.1007/s00406-009-0031-3 |
0.446 |
|
| 2010 |
Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine. 40: 239-51. PMID 19493369 DOI: 10.1017/S0033291709006035 |
0.544 |
|
| 2010 |
Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, Miyahara S, Rush AJ. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychological Medicine. 40: 41-50. PMID 19460188 DOI: 10.1017/S0033291709006011 |
0.594 |
|
| 2010 |
Casamassima F, Huang J, Fava M, Sachs GS, Smoller JW, Cassano GB, Lattanzi L, Fagerness J, Stange JP, Perlis RH. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 303-9. PMID 19388002 DOI: 10.1002/ajmg.b.30962 |
0.692 |
|
| 2010 |
Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A. Do atypical features affect outcome in depressed outpatients treated with citalopram? The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 15-30. PMID 19341509 DOI: 10.1017/S1461145709000182 |
0.558 |
|
| 2010 |
Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Molecular Psychiatry. 15: 856-67. PMID 19274052 DOI: 10.1038/Mp.2009.20 |
0.51 |
|
| 2010 |
Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 51: 124-129. DOI: 10.1016/S0033-3182(10)70672-1 |
0.682 |
|
| 2010 |
Petersen TJ, Pava JA, Buchin J, Matthews JD, Papakostas GI, Nierenberg AA, Holmes AJ, Bogdan R, Graves LM, Harley RM, Fava M. The role of cognitive-behavioral therapy and fluoxetine in prevention of recurrence of major depressive disorder Cognitive Therapy and Research. 34: 13-23. DOI: 10.1007/s10608-007-9166-6 |
0.536 |
|
| 2009 |
Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. Cns Spectrums. 14: 688-94. PMID 20394176 DOI: 10.1017/S1092852900023944 |
0.733 |
|
| 2009 |
Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y, Carlson BX, Marcus RN, Berman RM. Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163). Primary Care Companion to the Journal of Clinical Psychiatry. 11: 344-52. PMID 20098527 DOI: 10.4088/PCC.08m00744gre |
0.455 |
|
| 2009 |
Fava M. Augmentation and combination strategies for complicated depression. The Journal of Clinical Psychiatry. 70: e40. PMID 20031088 DOI: 10.4088/JCP.8001tx13c |
0.547 |
|
| 2009 |
Bryan C, Songer T, Brooks MM, Thase ME, Gaynes B, Klinkman M, Balasubramani GK, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. Do depressed patients with diabetes experience more side effects when treated with CitalopramThan their counterparts without diabetes? a STAR*D study. Primary Care Companion to the Journal of Clinical Psychiatry. 11: 186-96. PMID 19956455 DOI: 10.4088/Pcc.08.M00696 |
0.564 |
|
| 2009 |
Fava M, Mischoulon D. Folate in depression: efficacy, safety, differences in formulations, and clinical issues. The Journal of Clinical Psychiatry. 70: 12-7. PMID 19909688 DOI: 10.4088/JCP.8157su1c.03 |
0.538 |
|
| 2009 |
Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric Services (Washington, D.C.). 60: 1439-45. PMID 19880458 DOI: 10.1176/Ps.2009.60.11.1439 |
0.503 |
|
| 2009 |
Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M. Pattern of depressive symptoms in Parkinson's disease. Psychosomatics. 50: 448-54. PMID 19855029 DOI: 10.1176/appi.psy.50.5.448 |
0.714 |
|
| 2009 |
Montgomery SA, Fava M, Padmanabhan SK, Guico-Pabia CJ, Tourian KA. Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. International Clinical Psychopharmacology. 24: 296-305. PMID 19779354 DOI: 10.1097/YIC.0b013e32832fbb5a |
0.436 |
|
| 2009 |
Kornstein SG, Fava M, Jiang Q, Tourian KA. Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo. Psychopharmacology Bulletin. 42: 21-35. PMID 19752839 |
0.501 |
|
| 2009 |
Warden D, Trivedi MH, Wisniewski SR, Lesser IM, Mitchell J, Balasubramani GK, Fava M, Shores-Wilson K, Stegman D, Rush AJ. Identifying risk for attrition during treatment for depression. Psychotherapy and Psychosomatics. 78: 372-9. PMID 19738403 DOI: 10.1159/000235977 |
0.569 |
|
| 2009 |
Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/J.Psychres.2009.06.004 |
0.505 |
|
| 2009 |
Kashner TM, Trivedi MH, Wicker A, Fava M, Wisniewski SR, Rush AJ. The impact of nonclinical factors on care use for patients with depression: a STAR*D report. Cns Neuroscience & Therapeutics. 15: 320-32. PMID 19712127 DOI: 10.1111/J.1755-5949.2009.00091.X |
0.465 |
|
| 2009 |
Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/J.Psychres.2009.04.004 |
0.473 |
|
| 2009 |
Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. The Journal of Clinical Psychiatry. 70: 1636-44. PMID 19709502 DOI: 10.4088/Jcp.08M04603 |
0.76 |
|
| 2009 |
Kashner TM, Trivedi MH, Wicker A, Fava M, Shores-Wilson K, Wisniewski SR, Rush AJ. Release bias in accessing medical records in clinical trials: a STAR*D report. International Journal of Methods in Psychiatric Research. 18: 147-58. PMID 19701922 DOI: 10.1002/Mpr.286 |
0.39 |
|
| 2009 |
Fava M. Partial responders to antidepressant treatment: switching strategies. The Journal of Clinical Psychiatry. 70: e24. PMID 19653970 DOI: 10.4088/Jcp.8017Br3C |
0.407 |
|
| 2009 |
Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA. STAR*D: revising conventional wisdom. Cns Drugs. 23: 627-47. PMID 19594193 DOI: 10.2165/00023210-200923080-00001 |
0.444 |
|
| 2009 |
Fava M, Wisniewski SR, Thase ME, Baker RA, Tran QV, Pikalov A, Yang H, Marcus RN, Berman RM. Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies. Journal of Clinical Psychopharmacology. 29: 362-7. PMID 19593176 DOI: 10.1097/Jcp.0B013E3181Ac9B0B |
0.392 |
|
| 2009 |
Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 772-7. PMID 19574030 DOI: 10.1016/J.Euroneuro.2009.06.001 |
0.627 |
|
| 2009 |
Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nordic Journal of Psychiatry. 63: 420-5. PMID 19521922 DOI: 10.1080/08039480903015396 |
0.541 |
|
| 2009 |
Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. Journal of Clinical Psychopharmacology. 29: 222-30. PMID 19440075 DOI: 10.1097/JCP.0b013e3181a390ba |
0.379 |
|
| 2009 |
Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. The American Journal of Psychiatry. 166: 702-10. PMID 19411368 DOI: 10.1176/appi.ajp.2008.08081201 |
0.54 |
|
| 2009 |
Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. Cns Spectrums. 14: 197-206. PMID 19407731 DOI: 10.1017/S1092852900020216 |
0.544 |
|
| 2009 |
Weiss AP, Guidi J, Fava M. Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice. The Journal of Clinical Psychiatry. 70: 446-9. PMID 19403096 DOI: 10.4088/Jcp.08Com04901 |
0.334 |
|
| 2009 |
Gasic GP, Smoller JW, Perlis RH, Sun M, Lee S, Kim BW, Lee MJ, Holt DJ, Blood AJ, Makris N, Kennedy DK, Hoge RD, Calhoun J, Fava M, Gusella JF, et al. BDNF, relative preference, and reward circuitry responses to emotional communication. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 762-81. PMID 19388013 DOI: 10.1002/Ajmg.B.30944 |
0.555 |
|
| 2009 |
Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depression and Anxiety. 26: 612-21. PMID 19382183 DOI: 10.1002/Da.20568 |
0.579 |
|
| 2009 |
Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. The American Journal of Psychiatry. 166: 599-607. PMID 19339358 DOI: 10.1176/Appi.Ajp.2008.08071027 |
0.556 |
|
| 2009 |
Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ. Diurnal mood variation in outpatients with major depressive disorder. Depression and Anxiety. 26: 851-63. PMID 19306304 DOI: 10.1002/Da.20557 |
0.6 |
|
| 2009 |
Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1819-28. PMID 19295509 DOI: 10.1038/npp.2009.4 |
0.717 |
|
| 2009 |
Feldman G, Harley R, Kerrigan M, Jacobo M, Fava M. Change in emotional processing during a dialectical behavior therapy-based skills group for major depressive disorder. Behaviour Research and Therapy. 47: 316-21. PMID 19232571 DOI: 10.1016/j.brat.2009.01.005 |
0.484 |
|
| 2009 |
Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW, Moutier C, Fava M, Wisniewski SR, Luther J, Rush AJ. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. Journal of Affective Disorders. 117: 63-73. PMID 19217668 DOI: 10.1016/J.Jad.2009.01.002 |
0.537 |
|
| 2009 |
Perlis RH, Fava M, Trivedi MH, Alpert J, Luther JF, Wisniewski SR, Rush AJ. Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatrica Scandinavica. 119: 282-9. PMID 19207123 DOI: 10.1111/J.1600-0447.2008.01298.X |
0.843 |
|
| 2009 |
Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH. Family history of depression and therapeutic outcome: findings from STAR*D. The Journal of Clinical Psychiatry. 70: 185-95. PMID 19192454 DOI: 10.4088/Jcp.07M03571 |
0.568 |
|
| 2009 |
Matthews JD, Siefert C, Dording C, Denninger JW, Park L, van Nieuwenhuizen AO, Sklarsky K, Hilliker S, Homberger C, Rooney K, Fava M. An open study of aripiprazole and escitalopram for psychotic major depressive disorder. Journal of Clinical Psychopharmacology. 29: 73-6. PMID 19142112 DOI: 10.1097/Jcp.0B013E318193Dfb4 |
0.553 |
|
| 2009 |
Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M. Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies. International Clinical Psychopharmacology. 24: 19-25. PMID 19092448 DOI: 10.1097/YIC.0b013e328314dfaf |
0.482 |
|
| 2009 |
Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry. 14: 359-75. PMID 19065144 DOI: 10.1038/Mp.2008.125 |
0.629 |
|
| 2009 |
Bech P, Wilson P, Wessel T, Lunde M, Fava M. A validation analysis of two self-reported HAM-D6 versions. Acta Psychiatrica Scandinavica. 119: 298-303. PMID 19032701 DOI: 10.1111/j.1600-0447.2008.01289.x |
0.421 |
|
| 2009 |
Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug and Alcohol Dependence. 99: 248-60. PMID 18986774 DOI: 10.1016/J.Drugalcdep.2008.08.010 |
0.505 |
|
| 2009 |
Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 34-40. PMID 18823760 DOI: 10.1016/j.euroneuro.2008.08.009 |
0.389 |
|
| 2009 |
Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, Balasubramani GK, Fava M, Trivedi MH, John Rush A. Sex differences in response to citalopram: a STAR*D report. Journal of Psychiatric Research. 43: 503-11. PMID 18752809 DOI: 10.1016/J.Jpsychires.2008.07.002 |
0.462 |
|
| 2009 |
Fava M, Wiltse C, Walker D, Brecht S, Chen A, Perahia D. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder. Journal of Affective Disorders. 113: 263-71. PMID 18625521 DOI: 10.1016/j.jad.2008.05.023 |
0.446 |
|
| 2009 |
Fava M, Nelson JC, Thase ME, Trivedi MH. Easing the Burden of Treatment-Resistant Depression The Journal of Clinical Psychiatry. 70: 273-280. DOI: 10.4088/Jcp.Bm8017Ah1C |
0.515 |
|
| 2009 |
Fava M. Easing the Burden of Treatment-Resistant Depression: (Academic Highlights) The Journal of Clinical Psychiatry. 70: 273-280. DOI: 10.4088/Jcp.8017Ah1C |
0.513 |
|
| 2009 |
Friedman ES, Thase ME, Wisniewski SR, Trivedi MH, Biggs MM, Fava M, Warden D, Niederehe G, Luther JF, Rush AJ. Cognitive Therapy Augmentation versus CT Switch Treatment: A STAR*D Report International Journal of Cognitive Therapy. 2: 66-87. DOI: 10.1521/Ijct.2009.2.1.66 |
0.315 |
|
| 2009 |
Nierenberg AA, Trivedi MH, Gaynes BN, Mitchell J, Davis LL, Husain MM, Wisniewski SR, Fava M, Warden D, Luther JF, Van Nieuwenhuizen AO, Morris DW, Shelton RC, John Rush A. Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder Australian and New Zealand Journal of Psychiatry. 43: 956-967. DOI: 10.1080/00048670903001885 |
0.502 |
|
| 2009 |
Parikh R, Sonawalla S, Sharma-Pandey S, Farabaugh A, Yeung A, Safren S, Fava M. P.2.a.03l A cross-cultural, comparative study of the prevalence and symptom patterns of depression among college students European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70580-2 |
0.402 |
|
| 2008 |
Foster CE, Webster MC, Weissman MM, Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, Cerda G, Kornstein SG, Alpert JE, Wisniewski SR, Trivedi MH, Fava M, et al. Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment. Journal of Youth and Adolescence. 37: 906-916. PMID 25013241 DOI: 10.1007/S10964-007-9216-0 |
0.689 |
|
| 2008 |
Thase ME, Trivedi MH, Nelson JC, Fava M, Swanink R, Tran QV, Pikalov A, Yang H, Carlson BX, Marcus RN, Berman RM. Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies. Primary Care Companion to the Journal of Clinical Psychiatry. 10: 440-7. PMID 19287552 DOI: 10.4088/Pcc.V10N0603 |
0.534 |
|
| 2008 |
Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features. The Journal of Clinical Psychiatry. 69: 1928-36. PMID 19192475 DOI: 10.4088/Jcp.V69N1211 |
0.567 |
|
| 2008 |
Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. The Journal of Clinical Psychiatry. 69: 1513-28. PMID 19192434 DOI: 10.4088/Jcp.V69N1001 |
0.37 |
|
| 2008 |
Papakostas GI, Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 10: 439-51. PMID 19170401 |
0.482 |
|
| 2008 |
Howland RH, Wilson MG, Kornstein SG, Clayton AH, Trivedi MH, Wohlreich MM, Fava M. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 20: 209-18. PMID 19034753 DOI: 10.1080/10401230802437639 |
0.543 |
|
| 2008 |
McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR, Miyahara S, Nierenberg AA, Fava M, Rush AJ. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. The Journal of Clinical Psychiatry. 69: 1847-55. PMID 19026268 DOI: 10.4088/Jcp.V69N1201 |
0.511 |
|
| 2008 |
Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of Clinical Psychopharmacology. 28: 660-6. PMID 19011435 DOI: 10.1097/Jcp.0B013E31818Ad7D6 |
0.701 |
|
| Show low-probability matches. |